Cluster composition

Functions

Category	Name	IntersectionWithQuery	PValue	GenesInTerm	GenesInQuery	GenesInTermInQuery	ID
GeneOntologyMolecularFunction	aspartic-type endopeptidase activity	ERVK-6 ERVK-9 ERVK-19 ERVK-25	1.31e-04	37	141	4	GO:0004190
GeneOntologyMolecularFunction	aspartic-type peptidase activity	ERVK-6 ERVK-9 ERVK-19 ERVK-25	1.46e-04	38	141	4	GO:0070001
GeneOntologyMolecularFunction	extracellular matrix constituent, lubricant activity	MUC17 MUC4	2.94e-04	4	141	2	GO:0030197
GeneOntologyMolecularFunction	antigen binding	IGKV1-39 IGKV1-17 IGKV1-16 IGKV1-5 IGKV1D-39 IGKV1D-33 IGKV1D-12	4.09e-04	190	141	7	GO:0003823
GeneOntologyMolecularFunction	neuroligin family protein binding	NRXN3 NRXN1	4.88e-04	5	141	2	GO:0097109
GeneOntologyMolecularFunction	histone H3K36 trimethyltransferase activity	SETD2 SETD5	4.88e-04	5	141	2	GO:0140955
GeneOntologyMolecularFunction	ATPase inhibitor activity	TSC1 FNIP1	7.29e-04	6	141	2	GO:0042030
GeneOntologyBiologicalProcess	immunoglobulin production	IGKV1-39 IGKV1-27 IGKV1-17 IGKV1-16 IGKV1-12 IGKV1-6 IGLV3-10 IGKV1-5 IGKV1D-39 IGKV1D-33 IGKV1D-12 TP53BP1	1.41e-07	241	145	12	GO:0002377
GeneOntologyBiologicalProcess	production of molecular mediator of immune response	IGKV1-39 IGKV1-27 IGKV1-17 IGKV1-16 IGKV1-12 IGKV1-6 IGLV3-10 IGKV1-5 IGKV1D-39 IGKV1D-33 MAP3K7 IGKV1D-12 TP53BP1	5.61e-06	403	145	13	GO:0002440
GeneOntologyBiologicalProcess	adaptive immune response	IGKV1-39 IGKV1-27 IGKV1-17 IGKV1-16 IGKV1-12 IGKV1-6 SPN HLX TSC1 IGLV3-10 IGKV1-5 C5 IGKV1D-39 IGKV1D-33 MAP3K7 IGKV1D-12 MUC4 TP53BP1	2.48e-05	838	145	18	GO:0002250
GeneOntologyBiologicalProcess	synapse organization	CACNB4 OGT DSCAM MAPT DLGAP4 PCDHB6 ADGRL1 TSC1 NECTIN3 NRXN3 NRXN1 PLPPR4 SETD5 CAPRIN2 RAPGEF2	9.93e-05	685	145	15	GO:0050808
GeneOntologyBiologicalProcess	positive regulation of protein modification process	AKAP6 DIP2B OGT SPN ARHGEF5 MAGI3 RICTOR HUWE1 RB1CC1 AREG MET NRXN1 STRADA FNIP1 SPRTN RAPGEF2 MAP3K7 CDH5	1.04e-04	937	145	18	GO:0031401
GeneOntologyBiologicalProcess	positive regulation of phosphorylation	AKAP6 OGT DSCAM SPN MAPT ARHGEF5 MAGI3 RICTOR RB1CC1 AREG MET NRXN1 STRADA FNIP1 RAPGEF2 MAP3K7	1.23e-04	780	145	16	GO:0042327
GeneOntologyBiologicalProcess	regulation of phosphorylation	AKAP6 OGT DSCAM SPN MAPT ARHGEF5 MAGI3 RICTOR TSC1 RB1CC1 AREG ITPKB MET PTPRH NRXN1 STRADA PHLPP1 FNIP1 RAPGEF2 MAP3K7 CDH5	1.36e-04	1226	145	21	GO:0042325
GeneOntologyBiologicalProcess	positive regulation of phosphate metabolic process	AKAP6 OGT DSCAM SPN MAPT ARHGEF5 MAGI3 RICTOR RB1CC1 AREG MET NRXN1 STRADA FNIP1 RAPGEF2 MAP3K7 CDH5	1.52e-04	879	145	17	GO:0045937
GeneOntologyBiologicalProcess	positive regulation of phosphorus metabolic process	AKAP6 OGT DSCAM SPN MAPT ARHGEF5 MAGI3 RICTOR RB1CC1 AREG MET NRXN1 STRADA FNIP1 RAPGEF2 MAP3K7 CDH5	1.52e-04	879	145	17	GO:0010562
GeneOntologyCellularComponent	immunoglobulin complex	IGKV1-39 IGKV1-27 IGKV1-17 IGKV1-16 IGKV1-12 IGKV1-6 IGLV3-10 IGKV1-5 IGKV1D-39 IGKV1D-33 IGKV1D-12	2.65e-08	166	147	11	GO:0019814
GeneOntologyCellularComponent	Golgi lumen	MUC19 MUC16 MUC5B MUC12 MUC17 GPC2 MUC4 MUC20	1.03e-06	109	147	8	GO:0005796
GeneOntologyCellularComponent	cell-cell junction	AKAP6 DSC2 MAGI3 NECTIN3 CDH19 PLEKHG5 HMCN1 NRXN1 SCN1A SCN5A RAPGEF2 CDH5 PDZD2	2.83e-04	591	147	13	GO:0005911
GeneOntologyCellularComponent	anchoring junction	AKAP6 DSC2 ARHGEF5 MAGI3 IRF2 NECTIN3 CDH19 MAST2 PLEKHG5 HMCN1 NRXN1 PI4KA SCN1A SCN5A RAPGEF2 CDH5 PDZD2	5.16e-04	976	147	17	GO:0070161
GeneOntologyCellularComponent	cell-cell contact zone	AKAP6 DSC2 NECTIN3 SCN1A SCN5A	5.33e-04	94	147	5	GO:0044291
MousePheno	abnormal miniature excitatory postsynaptic currents	MAPT DLGAP4 MADD NRXN3 NRXN1 PLPPR4 SCN1A	1.91e-05	116	100	7	MP:0004753
Domain	ZnF_C2HC	ERVK-6 ZCCHC14 FAM90A7 FAM90A18 FAM90A9 FAM90A8 FAM90A10	9.29e-08	55	128	7	SM00343
Domain	Znf_CCHC	ERVK-6 ZCCHC14 FAM90A7 FAM90A18 FAM90A9 FAM90A8 FAM90A10	9.29e-08	55	128	7	IPR001878
Domain	VWF_type-D	MUC19 MUC5B MUC4	1.65e-04	16	128	3	IPR001846
Domain	VWFD	MUC19 MUC5B MUC4	1.65e-04	16	128	3	PS51233
Domain	VWD	MUC19 MUC5B MUC4	1.65e-04	16	128	3	SM00216
Domain	VWD	MUC19 MUC5B MUC4	1.65e-04	16	128	3	PF00094
Domain	EGF	AREG MMRN1 NRXN3 HMCN1 NRXN1 MUC4	2.32e-04	126	128	6	PF00008
Domain	Mib_Herc2	MIB1 HECTD1	2.77e-04	4	128	2	IPR010606
Domain	MIB_HERC2	MIB1 HECTD1	2.77e-04	4	128	2	PS51416
Domain	MIB_HERC2	MIB1 HECTD1	2.77e-04	4	128	2	PF06701
Domain	EGF_1	MUC12 AREG MMRN1 NRXN3 HMCN1 NRXN1 MUC17 MUC4	3.78e-04	255	128	8	PS00022
Domain	SEA	MUC16 MUC12 MUC17	4.40e-04	22	128	3	PF01390
Domain	EGF-like_CS	MUC12 AREG MMRN1 NRXN3 HMCN1 NRXN1 MUC17 MUC4	4.41e-04	261	128	8	IPR013032
Domain	EGF_2	MUC12 AREG MMRN1 NRXN3 HMCN1 NRXN1 MUC17 MUC4	4.88e-04	265	128	8	PS01186
Domain	SEA	MUC16 MUC12 MUC17	5.04e-04	23	128	3	PS50024
Domain	SEA_dom	MUC16 MUC12 MUC17	5.04e-04	23	128	3	IPR000082
Domain	Cadherin_C	DSC2 CDH19 CDH5	6.48e-04	25	128	3	PF01049
Domain	Cadherin_cytoplasmic-dom	DSC2 CDH19 CDH5	6.48e-04	25	128	3	IPR000233
Domain	Na_trans_cytopl	SCN1A SCN5A	6.87e-04	6	128	2	PF11933
Domain	Na_trans_cytopl	SCN1A SCN5A	6.87e-04	6	128	2	IPR024583
Domain	HECT	HUWE1 UBE3C HECTD1	8.15e-04	27	128	3	PF00632
Domain	HECTc	HUWE1 UBE3C HECTD1	8.15e-04	27	128	3	SM00119
Domain	HECT_dom	HUWE1 UBE3C HECTD1	8.15e-04	27	128	3	IPR000569
Domain	HECT	HUWE1 UBE3C HECTD1	8.15e-04	27	128	3	PS50237
Domain	DH_1	ARHGEF5 PLEKHG5 PLEKHG1 PLEKHG3	9.17e-04	63	128	4	PS00741
Domain	Syndecan	NRXN3 NRXN1	9.57e-04	7	128	2	PF01034
Domain	Syndecan/Neurexin_dom	NRXN3 NRXN1	9.57e-04	7	128	2	IPR027789
Domain	Catenin_binding_dom	DSC2 CDH19 CDH5	1.01e-03	29	128	3	IPR027397
Domain	-	DSC2 CDH19 CDH5	1.01e-03	29	128	3	4.10.900.10
Domain	EGF	AREG MMRN1 NRXN3 HMCN1 NRXN1 MUC17 MUC4	1.19e-03	235	128	7	SM00181
Domain	EGF_3	AREG MMRN1 NRXN3 HMCN1 NRXN1 MUC17 MUC4	1.19e-03	235	128	7	PS50026
Domain	RhoGEF	ARHGEF5 PLEKHG5 PLEKHG1 PLEKHG3	1.22e-03	68	128	4	SM00325
Domain	RhoGEF	ARHGEF5 PLEKHG5 PLEKHG1 PLEKHG3	1.36e-03	70	128	4	PF00621
Domain	DH_2	ARHGEF5 PLEKHG5 PLEKHG1 PLEKHG3	1.36e-03	70	128	4	PS50010
Domain	-	ARHGEF5 PLEKHG5 PLEKHG1 PLEKHG3	1.43e-03	71	128	4	1.20.900.10
Domain	DH-domain	ARHGEF5 PLEKHG5 PLEKHG1 PLEKHG3	1.43e-03	71	128	4	IPR000219
Domain	EGF-like_dom	AREG MMRN1 NRXN3 HMCN1 NRXN1 MUC17 MUC4	1.66e-03	249	128	7	IPR000742
Domain	Na_channel_asu	SCN1A SCN5A	2.02e-03	10	128	2	IPR001696
Domain	Na_trans_assoc	SCN1A SCN5A	2.02e-03	10	128	2	IPR010526
Domain	Na_trans_assoc	SCN1A SCN5A	2.02e-03	10	128	2	PF06512
Domain	IQ	SCN1A SCN5A UBE3C MYO18B	2.33e-03	81	128	4	SM00015
Domain	SET	KMT2C SETD2 SETD5	2.77e-03	41	128	3	PF00856
Domain	C8	MUC19 MUC5B	2.94e-03	12	128	2	PF08742
Domain	TIL	MUC19 MUC5B	2.94e-03	12	128	2	PF01826
Domain	IQ_motif_EF-hand-BS	SCN1A SCN5A UBE3C MYO18B	3.41e-03	90	128	4	IPR000048
Domain	Unchr_dom_Cys-rich	MUC19 MUC5B	3.46e-03	13	128	2	IPR014853
Domain	C8	MUC19 MUC5B	3.46e-03	13	128	2	SM00832
Domain	IQ	SCN1A SCN5A UBE3C MYO18B	3.84e-03	93	128	4	PS50096
Domain	SET	KMT2C SETD2 SETD5	3.85e-03	46	128	3	SM00317
Domain	TIL_dom	MUC19 MUC5B	4.02e-03	14	128	2	IPR002919
Domain	SEA	MUC16 MUC17	4.02e-03	14	128	2	SM00200
Domain	Neurexin-like	NRXN3 NRXN1	4.02e-03	14	128	2	IPR003585
Domain	4.1m	NRXN3 NRXN1	4.02e-03	14	128	2	SM00294
Domain	-	MUC16 MUC17	4.62e-03	15	128	2	3.30.70.960
Domain	SET_dom	KMT2C SETD2 SETD5	4.87e-03	50	128	3	IPR001214
Domain	SET	KMT2C SETD2 SETD5	4.87e-03	50	128	3	PS50280
Domain	Post-SET_dom	KMT2C SETD2	5.25e-03	16	128	2	IPR003616
Domain	PostSET	KMT2C SETD2	5.25e-03	16	128	2	SM00508
Domain	POST_SET	KMT2C SETD2	5.25e-03	16	128	2	PS50868
Domain	EGF-type_Asp/Asn_hydroxyl_site	MMRN1 NRXN3 HMCN1 NRXN1	6.10e-03	106	128	4	IPR000152
Domain	CTCK_1	MUC19 MUC5B	6.64e-03	18	128	2	PS01185
Domain	Cadherin_CS	DSC2 PCDHB6 CDH19 CDH5	6.73e-03	109	128	4	IPR020894
Pathway	REACTOME_CD22_MEDIATED_BCR_REGULATION	IGKV1-39 IGKV1-33 IGKV1-17 IGKV1-16 IGKV1-12 IGKV1-5 IGKV1D-39 IGKV1D-33 IGKV1D-16 IGKV1D-12	1.84e-11	61	103	10	M27581
Pathway	REACTOME_FCERI_MEDIATED_MAPK_ACTIVATION	IGKV1-39 IGKV1-33 IGKV1-17 IGKV1-16 IGKV1-12 FOS IGKV1-5 IGKV1D-39 IGKV1D-33 IGKV1D-16 IGKV1D-12	3.24e-11	87	103	11	M27205
Pathway	REACTOME_FCGR_ACTIVATION	IGKV1-39 IGKV1-33 IGKV1-17 IGKV1-16 IGKV1-12 IGKV1-5 IGKV1D-39 IGKV1D-33 IGKV1D-16 IGKV1D-12	6.60e-11	69	103	10	M27108
Pathway	REACTOME_SCAVENGING_OF_HEME_FROM_PLASMA	IGKV1-39 IGKV1-33 IGKV1-17 IGKV1-16 IGKV1-12 IGKV1-5 IGKV1D-39 IGKV1D-33 IGKV1D-16 IGKV1D-12	6.60e-11	69	103	10	M27150
Pathway	REACTOME_CREATION_OF_C4_AND_C2_ACTIVATORS	IGKV1-39 IGKV1-33 IGKV1-17 IGKV1-16 IGKV1-12 IGKV1-5 IGKV1D-39 IGKV1D-33 IGKV1D-16 IGKV1D-12	8.86e-11	71	103	10	M1078
Pathway	REACTOME_ROLE_OF_LAT2_NTAL_LAB_ON_CALCIUM_MOBILIZATION	IGKV1-39 IGKV1-33 IGKV1-17 IGKV1-16 IGKV1-12 IGKV1-5 IGKV1D-39 IGKV1D-33 IGKV1D-16 IGKV1D-12	8.86e-11	71	103	10	M27203
Pathway	REACTOME_INITIAL_TRIGGERING_OF_COMPLEMENT	IGKV1-39 IGKV1-33 IGKV1-17 IGKV1-16 IGKV1-12 IGKV1-5 IGKV1D-39 IGKV1D-33 IGKV1D-16 IGKV1D-12	2.99e-10	80	103	10	M6121
Pathway	REACTOME_ROLE_OF_PHOSPHOLIPIDS_IN_PHAGOCYTOSIS	IGKV1-39 IGKV1-33 IGKV1-17 IGKV1-16 IGKV1-12 IGKV1-5 IGKV1D-39 IGKV1D-33 IGKV1D-16 IGKV1D-12	3.84e-10	82	103	10	M27110
Pathway	REACTOME_ANTIGEN_ACTIVATES_B_CELL_RECEPTOR_BCR_LEADING_TO_GENERATION_OF_SECOND_MESSENGERS	IGKV1-39 IGKV1-33 IGKV1-17 IGKV1-16 IGKV1-12 IGKV1-5 IGKV1D-39 IGKV1D-33 IGKV1D-16 IGKV1D-12	6.21e-10	86	103	10	M601
Pathway	REACTOME_FCERI_MEDIATED_CA_2_MOBILIZATION	IGKV1-39 IGKV1-33 IGKV1-17 IGKV1-16 IGKV1-12 IGKV1-5 IGKV1D-39 IGKV1D-33 IGKV1D-16 IGKV1D-12	6.21e-10	86	103	10	M27206
Pathway	REACTOME_COMPLEMENT_CASCADE	IGKV1-39 IGKV1-33 IGKV1-17 IGKV1-16 IGKV1-12 IGKV1-5 C5 IGKV1D-39 IGKV1D-33 IGKV1D-16 IGKV1D-12	6.97e-10	115	103	11	M19752
Pathway	REACTOME_PARASITE_INFECTION	IGKV1-39 IGKV1-33 IGKV1-17 IGKV1-16 IGKV1-12 NCKIPSD IGKV1-5 IGKV1D-39 IGKV1D-33 IGKV1D-16 IGKV1D-12	7.65e-10	116	103	11	M29843
Pathway	REACTOME_DEFECTIVE_GALNT3_CAUSES_HFTC	MUC16 MUC5B MUC12 MUC17 MUC4 MUC20	9.91e-10	16	103	6	M27410
Pathway	REACTOME_DEFECTIVE_C1GALT1C1_CAUSES_TNPS	MUC16 MUC5B MUC12 MUC17 MUC4 MUC20	1.52e-09	17	103	6	M27412
Pathway	REACTOME_FCGR3A_MEDIATED_IL10_SYNTHESIS	IGKV1-39 IGKV1-33 IGKV1-17 IGKV1-16 IGKV1-12 IGKV1-5 IGKV1D-39 IGKV1D-33 IGKV1D-16 IGKV1D-12	1.68e-09	95	103	10	M29842
Pathway	REACTOME_BINDING_AND_UPTAKE_OF_LIGANDS_BY_SCAVENGER_RECEPTORS	IGKV1-39 IGKV1-33 IGKV1-17 IGKV1-16 IGKV1-12 IGKV1-5 IGKV1D-39 IGKV1D-33 IGKV1D-16 IGKV1D-12	2.28e-09	98	103	10	M27152
Pathway	REACTOME_FCERI_MEDIATED_NF_KB_ACTIVATION	IGKV1-39 IGKV1-33 IGKV1-17 IGKV1-16 IGKV1-12 IGKV1-5 IGKV1D-39 IGKV1D-33 MAP3K7 IGKV1D-16 IGKV1D-12	4.20e-09	136	103	11	M27207
Pathway	REACTOME_TERMINATION_OF_O_GLYCAN_BIOSYNTHESIS	MUC19 MUC16 MUC5B MUC17 MUC4 MUC20	6.52e-09	21	103	6	MM15706
Pathway	REACTOME_FCGAMMA_RECEPTOR_FCGR_DEPENDENT_PHAGOCYTOSIS	IGKV1-39 IGKV1-33 IGKV1-17 IGKV1-16 IGKV1-12 NCKIPSD IGKV1-5 IGKV1D-39 IGKV1D-33 IGKV1D-16 IGKV1D-12	7.14e-09	143	103	11	M27107
Pathway	REACTOME_FC_EPSILON_RECEPTOR_FCERI_SIGNALING	IGKV1-39 IGKV1-33 IGKV1-17 IGKV1-16 IGKV1-12 FOS IGKV1-5 IGKV1D-39 IGKV1D-33 MAP3K7 IGKV1D-16 IGKV1D-12	1.05e-08	186	103	12	M27175
Pathway	REACTOME_TERMINATION_OF_O_GLYCAN_BIOSYNTHESIS	MUC16 MUC5B MUC12 MUC17 MUC4 MUC20	1.20e-08	23	103	6	M556
Pathway	REACTOME_DECTIN_2_FAMILY	MUC16 MUC5B MUC12 MUC17 MUC4 MUC20	2.69e-08	26	103	6	M27483
Pathway	REACTOME_SIGNALING_BY_THE_B_CELL_RECEPTOR_BCR	IGKV1-39 IGKV1-33 IGKV1-17 IGKV1-16 IGKV1-12 IGKV1-5 IGKV1D-39 IGKV1D-33 MAP3K7 IGKV1D-16 IGKV1D-12	3.39e-08	166	103	11	M608
Pathway	REACTOME_ANTI_INFLAMMATORY_RESPONSE_FAVOURING_LEISHMANIA_PARASITE_INFECTION	IGKV1-39 IGKV1-33 IGKV1-17 IGKV1-16 IGKV1-12 IGKV1-5 IGKV1D-39 IGKV1D-33 IGKV1D-16 IGKV1D-12	4.79e-08	134	103	10	M29840
Pathway	REACTOME_CELL_SURFACE_INTERACTIONS_AT_THE_VASCULAR_WALL	IGKV1-39 IGKV1-33 IGKV1-17 IGKV1-16 IGKV1-12 SPN IGKV1-5 IGKV1D-39 IGKV1D-33 IGKV1D-16 IGKV1D-12	1.67e-07	194	103	11	M16312
Pathway	REACTOME_POTENTIAL_THERAPEUTICS_FOR_SARS	IGKV1-39 IGKV1-33 IGKV1-17 IGKV1-16 IGKV1-12 IGKV1-5 IGKV1D-39 IGKV1D-33 IGKV1D-16 IGKV1D-12	1.79e-07	154	103	10	M39007
Pathway	REACTOME_LEISHMANIA_INFECTION	IGKV1-39 IGKV1-33 IGKV1-17 IGKV1-16 IGKV1-12 NCKIPSD IGKV1-5 IGKV1D-39 IGKV1D-33 IGKV1D-16 IGKV1D-12	5.64e-07	219	103	11	M29836
Pathway	REACTOME_IMMUNOREGULATORY_INTERACTIONS_BETWEEN_A_LYMPHOID_AND_A_NON_LYMPHOID_CELL	IGKV1-39 IGKV1-33 IGKV1-17 IGKV1-16 IGKV1-12 IGKV1-5 IGKV1D-39 IGKV1D-33 IGKV1D-16 IGKV1D-12	1.24e-06	190	103	10	M8240
Pathway	REACTOME_O_LINKED_GLYCOSYLATION_OF_MUCINS	MUC19 MUC16 MUC5B MUC17 MUC4 MUC20	4.78e-06	60	103	6	MM15636
Pathway	REACTOME_O_LINKED_GLYCOSYLATION_OF_MUCINS	MUC16 MUC5B MUC12 MUC17 MUC4 MUC20	5.80e-06	62	103	6	M546
Pathway	REACTOME_DISEASES_ASSOCIATED_WITH_O_GLYCOSYLATION_OF_PROTEINS	MUC16 MUC5B MUC12 MUC17 MUC4 MUC20	9.97e-06	68	103	6	M27303
Pathway	REACTOME_SARS_COV_INFECTIONS	IGKV1-39 IGKV1-33 IGKV1-17 IGKV1-16 IGKV1-12 NUP214 IGKV1-5 GPC2 IGKV1D-39 IGKV1D-33 MAP3K7 IGKV1D-16 IGKV1D-12	3.78e-05	471	103	13	M39009
Pathway	REACTOME_INNATE_IMMUNE_SYSTEM	IGKV1-39 IGKV1-33 IGKV1-17 IGKV1-16 IGKV1-12 FOS NCKIPSD MUC16 MUC5B MUC12 HUWE1 IGKV1-5 MUC17 C5 IGKV1D-39 IGKV1D-33 MAP3K7 IGKV1D-16 IGKV1D-12 MUC4 MUC20	5.49e-05	1128	103	21	M1036
Pathway	REACTOME_C_TYPE_LECTIN_RECEPTORS_CLRS	MUC16 MUC5B MUC12 MUC17 MAP3K7 MUC4 MUC20	7.34e-05	140	103	7	M27484
Pathway	REACTOME_DISEASES_OF_GLYCOSYLATION	MUC16 MUC5B MUC12 MUC17 GPC2 MUC4 MUC20	8.40e-05	143	103	7	M27275
Pathway	REACTOME_O_LINKED_GLYCOSYLATION	MUC19 MUC16 MUC5B MUC17 MUC4 MUC20	1.45e-04	109	103	6	MM15164
Pathway	REACTOME_O_LINKED_GLYCOSYLATION	MUC16 MUC5B MUC12 MUC17 MUC4 MUC20	1.60e-04	111	103	6	M27416
Pathway	REACTOME_HEMOSTASIS	IGKV1-39 IGKV1-33 IGKV1-17 IGKV1-16 IGKV1-12 SPN IRF2 MMRN1 IGKV1-5 TEX264 IGKV1D-39 IGKV1D-33 IGKV1D-16 IGKV1D-12	4.09e-04	679	103	14	M8395
Pathway	KEGG_CELL_ADHESION_MOLECULES_CAMS	SPN NECTIN3 NEO1 NRXN3 NRXN1 CDH5	4.26e-04	133	103	6	M16476
Pathway	REACTOME_VIRAL_INFECTION_PATHWAYS	IGKV1-39 IGKV1-33 IGKV1-17 IGKV1-16 IGKV1-12 NUP214 MED1 IGKV1-5 GPC2 TAF4 IGKV1D-39 IGKV1D-33 MAP3K7 IGKV1D-16 IGKV1D-12 MED13	6.84e-04	888	103	16	M48034
Pathway	REACTOME_INFECTIOUS_DISEASE	IGKV1-39 IGKV1-33 IGKV1-17 IGKV1-16 IGKV1-12 NCKIPSD NUP214 MED1 MET IGKV1-5 GPC2 TAF4 IGKV1D-39 IGKV1D-33 MAP3K7 IGKV1D-16 IGKV1D-12 MED13	7.79e-04	1081	103	18	M27548
Pathway	REACTOME_ADAPTIVE_IMMUNE_SYSTEM	IGKV1-39 IGKV1-33 IGKV1-17 IGKV1-16 IGKV1-12 RICTOR HUWE1 IGKV1-5 UBE3C IGKV1D-39 IGKV1D-33 MAP3K7 IGKV1D-16 IGKV1D-12 HECTD1	9.67e-04	828	103	15	M1058
Pathway	WP_HISTONE_MODIFICATIONS	KMT2C SETD2 SETD5 AEBP2	1.29e-03	65	103	4	M39374
Pathway	WP_PLEURAL_MESOTHELIOMA	OGT TSC1 RB1CC1 CDH19 AREG MET KMT2C SETD2 SETD5 CDH5	1.38e-03	439	103	10	M42563
Pathway	KEGG_MEDICUS_REFERENCE_STRAD_STK11_TSC_SIGNALING_PATHWAY	TSC1 STRADA	1.44e-03	8	103	2	M47916
Pathway	REACTOME_NEUREXINS_AND_NEUROLIGINS	DLGAP4 NRXN3 NRXN1	1.61e-03	32	103	3	MM15326
Pubmed	Characteristics of the immunoglobulin Vkappa genes, pseudogenes, relics and orphons in the mouse genome.	IGKV1-39 IGKV1-27 IGKV1-17 IGKV1-16 IGKV1-6 IGKV1-5 IGKV1D-39 IGKV1D-33	1.33e-14	20	152	8	10427970
Pubmed	Characterization and evolution of the novel gene family FAM90A in primates originated by multiple duplication and rearrangement events.	FAM90A17 FAM90A19 FAM90A7 FAM90A18 FAM90A9 FAM90A8 FAM90A16 FAM90A10	1.12e-13	25	152	8	17684299
Pubmed	Variation in the crossover point of kappa immunoglobulin gene V-J recombination: evidence from a cryptic gene.	IGKV1-39 IGKV1-17 IGKV1-16 IGKV1-6 IGKV1-5 IGKV1D-39	5.24e-13	9	152	6	6777049
Pubmed	Mucin gene expression in human laryngeal epithelia: effect of laryngopharyngeal reflux.	MUC19 MUC16 MUC5B MUC12 MUC17 MUC4 MUC20	8.10e-13	18	152	7	18834073
Pubmed	Human myeloperoxidase in innate and acquired immunity.	IGKV1-39 IGKV1-27 IGKV1-12 IGKV1-5 IGKV1D-39 IGKV1D-33 IGKV1D-12	8.10e-13	18	152	7	20399194
Pubmed	A central chaperone-like role for 14-3-3 proteins in human cells.	DIP2B EMC1 DSC2 MAPT ARHGEF5 KCTD8 NCKIPSD MAGI3 RICTOR MAST2 NCKAP5L MADD ITPKB CEP170 ZCCHC14 PLEKHG1 PLEKHG3 PI4KA NAV2 FNIP1 RAPGEF2 HECTD1 TMCC1	4.26e-12	861	152	23	36931259
Pubmed	Analysis of the multi-copy gene family FAM90A as a copy number variant in different ethnic backgrounds.	FAM90A17 FAM90A19 FAM90A7 FAM90A9 FAM90A8 FAM90A16 FAM90A10	6.13e-12	23	152	7	18602769
Pubmed	Structure and implied functions of truncated B-cell receptor mRNAs in early embryo and adult mesenchymal stem cells: Cdelta replaces Cmu in mu heavy chain-deficient mice.	IGKV1-39 IGKV1-17 IGKV1-16 IGKV1-6 IGKV1-5 IGKV1D-39	4.87e-11	16	152	6	17124007
Pubmed	FBXO22 promotes leukemogenesis by targeting BACH1 in MLL-rearranged acute myeloid leukemia.	IGKV1-39 IGKV1-33 IGKV1-27 IGKV1-17 IGKV1-16 PCDHB6 TSC1 BRD3 NUP214 KMT2C NAV2 RP1 TAF4 IGKV1D-39 IGKV1D-33 IGKV1D-16 MUC4	7.68e-11	497	152	17	36774506
Pubmed	A dual-activity topoisomerase complex regulates mRNA translation and turnover.	CRYBG2 WDR70 HECTD4 ADGRL1 BTAF1 NUP214 HUWE1 MAST2 PLEKHG5 MADD ZCCHC14 PLEKHG1 KMT2C SETD5 PI4KA TTLL4 SCN5A NAV2 HMGXB3 GPC2 UBE3C HECTD1 MED13	5.82e-10	1105	152	23	35748872
Pubmed	Amino acid sequence of the variable region of M149 mouse myeloma light chain: comparison with the nucleotide sequence of K2 and K3 clones.	IGKV1-39 IGKV1-27 IGKV1-5 IGKV1D-39 IGKV1D-33	6.75e-10	11	152	5	6795447
Pubmed	Multiple related immunoglobulin variable-region genes identified by cloning and sequence analysis.	IGKV1-39 IGKV1-27 IGKV1-5 IGKV1D-39 IGKV1D-33	6.75e-10	11	152	5	279004
Pubmed	Organization and complete sequence of identical embryonic and plasmacytoma kappa V-region genes.	IGKV1-39 IGKV1-27 IGKV1-5 IGKV1D-39 IGKV1D-33	6.75e-10	11	152	5	6767723
Pubmed	Prediction of the coding sequences of mouse homologues of KIAA gene: III. the complete nucleotide sequences of 500 mouse KIAA-homologous cDNAs identified by screening of terminal sequences of cDNA clones randomly sampled from size-fractionated libraries.	AKAP6 EMC1 SNX17 HECTD4 PLEKHG5 KMT2C NRXN3 PLPPR4 ZNF608 TTLL4 CAPRIN2 MIB1 ANKIB1 NAV2 HMGXB3 MED13	1.68e-09	529	152	16	14621295
Pubmed	Prediction of the coding sequences of mouse homologues of KIAA gene: II. The complete nucleotide sequences of 400 mouse KIAA-homologous cDNAs identified by screening of terminal sequences of cDNA clones randomly sampled from size-fractionated libraries.	DLGAP4 ADGRL1 TSC1 NUP214 MADD ZCCHC14 PLEKHG1 SETD5 PDE4DIP FNIP1 PPIP5K1 UBE3C SON PDZD2	3.64e-09	407	152	14	12693553
Pubmed	Genome-wide CRISPR screen identifies HNRNPL as a prostate cancer dependency regulating RNA splicing.	SLC12A6 DIP2B OGT MAPT WDR70 HECTD4 MAGI3 ADGRL1 BTAF1 HUWE1 ITPKB CEP170 KMT2C ZNF608 SETD5 PLEKHG3 ANKIB1 FNIP1 TAF4 UBE3C RAPGEF2 HECTD1 TMCC1 PDZD2	3.39e-08	1489	152	24	28611215
Pubmed	IMGT/GENE-DB: a comprehensive database for human and mouse immunoglobulin and T cell receptor genes.	IGKV1-39 IGKV1-17 IGKV1-16 IGKV1-6 IGKV1-5 IGKV1D-39 IGKV1D-33	4.93e-08	77	152	7	15608191
Pubmed	Integrative analysis of the cancer genome atlas and cancer cell lines encyclopedia large-scale genomic databases: MUC4/MUC16/MUC20 signature is associated with poor survival in human carcinomas.	MUC16 MUC4 MUC20	8.18e-08	3	152	3	30236127
Pubmed	Differential Expression of MUC12, MUC16, and MUC20 in Patients with Active and Remission Ulcerative Colitis.	MUC16 MUC12 MUC20	8.18e-08	3	152	3	26770020
Pubmed	Clonal characterization of the human IgG antibody repertoire to Haemophilus influenzae type b polysaccharide. IV. The less frequently expressed VL are heterogeneous.	IGKV1-33 IGKV1-6 IGKV1D-33	8.18e-08	3	152	3	1940382
Pubmed	Substrate trapping proteomics reveals targets of the βTrCP2/FBXW11 ubiquitin ligase.	OGT MAGI3 MAST2 NCKAP5L HMCN1 AEBP2 FNIP1 RAPGEF2	1.02e-07	128	152	8	25332235
Pubmed	Prediction of the coding sequences of mouse homologues of KIAA gene: I. The complete nucleotide sequences of 100 mouse KIAA-homologous cDNAs identified by screening of terminal sequences of cDNA clones randomly sampled from size-fractionated libraries.	DIP2B HUWE1 RB1CC1 MAST2 NRXN1 PHLPP1 RAPGEF2	1.16e-07	87	152	7	12465718
Pubmed	An antibody-based proximity labeling map reveals mechanisms of SARS-CoV-2 inhibition of antiviral immunity.	WDR70 TSC1 NUP214 NECTIN3 HUWE1 NCKAP5L GGCX MADD CEP170 ZCCHC14 SETD2 NEO1 TEX264 TTLL4 UBE3C HECTD1	1.55e-07	733	152	16	34672954
Pubmed	Multilevel proteomics reveals host perturbations by SARS-CoV-2 and SARS-CoV.	SLC12A6 TMEM248 SGCB DLGAP4 SNX17 C11orf24 BTAF1 NECTIN3 HUWE1 RB1CC1 AREG MET SETD2 NEO1 PDE4DIP ANKIB1 C5 TAF4 UBE3C	2.15e-07	1061	152	19	33845483
Pubmed	Recognition of unknown conserved alternatively spliced exons.	PPIP5K1 TP53BP1 SON	3.26e-07	4	152	3	16110330
Pubmed	Neuron-specific protein network mapping of autism risk genes identifies shared biological mechanisms and disease-relevant pathologies.	CACNB4 EMC1 MAPT DLGAP4 ADGRL1 RICTOR HUWE1 MADD CEP170 MET NEO1 NRXN1 PLPPR4 PI4KA SCN1A PDE4DIP MAP3K7 TMCC1 TP53BP1	6.28e-07	1139	152	19	36417873
Pubmed	Activity-Based Probes for HECT E3 Ubiquitin Ligases.	HUWE1 UBE3C HECTD1	8.13e-07	5	152	3	28425671
Pubmed	Spatiotemporal profile of postsynaptic interactomes integrates components of complex brain disorders.	TRERF1 DIP2B CACNB4 OGT DSCAM DLGAP4 HECTD4 TSC1 HUWE1 CEP170 NRXN1 PLPPR4 PI4KA PDE4DIP TAF4 RAPGEF2 TP53BP1	1.19e-06	963	152	17	28671696
Pubmed	Expression of Muc19/Smgc gene products during murine sublingual gland development: cytodifferentiation and maturation of salivary mucous cells.	MUC19 MUC16 MUC5B	1.62e-06	6	152	3	19110483
Pubmed	Human endogenous retrovirus HERV-K(HML-2) proviruses with Rec protein coding capacity and transcriptional activity.	ERVK-6 ERVK-9 ERVK-19	1.62e-06	6	152	3	15063128
Pubmed	Protein-protein interactions between large proteins: two-hybrid screening using a functionally classified library composed of long cDNAs.	MAGI3 MAST2 MADD NRXN1 HECTD1 MED13 PDZD2	1.79e-06	130	152	7	12421765
Pubmed	Systematic bromodomain protein screens identify homologous recombination and R-loop suppression pathways involved in genome integrity.	CCNL2 OGT DSC2 MAPT RICTOR BRD3 MAST2 NCKAP5L GGCX CEP170 SETD2 ZNF608 SETD5 SCN5A CAPRIN2 TAF4 RAPGEF2 SON	2.04e-06	1116	152	18	31753913
Pubmed	Prediction of the coding sequences of unidentified human genes. VII. The complete sequences of 100 new cDNA clones from brain which can code for large proteins in vitro.	AKAP6 HUWE1 MADD PPIP5K1 RAPGEF2 PDZD2	6.73e-06	104	152	6	9205841
Pubmed	Prediction of the coding sequences of unidentified human genes. IX. The complete sequences of 100 new cDNA clones from brain which can code for large proteins in vitro.	ZCCHC14 NRXN3 NRXN1 PLEKHG3 PHLPP1 MED13	7.11e-06	105	152	6	9628581
Pubmed	A human skeletal muscle interactome centered on proteins involved in muscular dystrophies: LGMD interactome.	AKAP6 SLC12A6 SGCB MAST2 CEP170 NEO1 PDE4DIP MYO18B MAP3K7 MED13 SON	1.29e-05	497	152	11	23414517
Pubmed	DNA Damage Regulates Translation through β-TRCP Targeting of CReP.	AEBP2 FNIP1 RAPGEF2 MED13	1.65e-05	35	152	4	26091241
Pubmed	Genomewide screening for fusogenic human endogenous retrovirus envelopes identifies syncytin 2, a gene conserved on primate evolution.	ERVK-6 ERVK-9 ERVK-19	1.75e-05	12	152	3	14557543
Pubmed	Evolutionary dynamics of the human immunoglobulin kappa locus and the germline repertoire of the Vkappa genes.	IGKV1D-39 IGKV1D-33 IGKV1D-16 IGKV1D-12	1.85e-05	36	152	4	11298326
Pubmed	The microtubule-associated protein tau is extensively modified with O-linked N-acetylglucosamine.	OGT MAPT	1.90e-05	2	152	2	8910513
Pubmed	Neurexin-3 subsynaptic densities are spatially distinct from Neurexin-1 and essential for excitatory synapse nanoscale organization in the hippocampus.	NRXN3 NRXN1	1.90e-05	2	152	2	37543682
Pubmed	Neurexin I alpha is a major alpha-latrotoxin receptor that cooperates in alpha-latrotoxin action.	NRXN3 NRXN1	1.90e-05	2	152	2	9430716
Pubmed	Setd5, but not Setd2, is indispensable for retinal cell survival and proliferation.	SETD2 SETD5	1.90e-05	2	152	2	36349512
Pubmed	Genetic analysis of alpha-latrotoxin receptors reveals functional interdependence of CIRL/latrophilin 1 and neurexin 1 alpha.	ADGRL1 NRXN1	1.90e-05	2	152	2	11741895
Pubmed	Mutations in plasticity-related-gene-1 (PRG-1) protein contribute to hippocampal seizure susceptibility and modify epileptic phenotype.	PLPPR4 SCN1A	1.90e-05	2	152	2	36977636
Pubmed	Phage display of a human antibody against Clostridium tetani toxin.	IGKV1-39 IGKV1D-39	1.90e-05	2	152	2	7926831
Pubmed	Association of a polymorphism in the NRXN3 gene with the degree of smoking in schizophrenia: a preliminary study.	NRXN3 NRXN1	1.90e-05	2	152	2	19658047
Pubmed	Nkx3.2-mediated repression of Runx2 promotes chondrogenic differentiation.	NKX3-2 RUNX2	1.90e-05	2	152	2	15703179
Pubmed	Immunocytochemistry for MUC4 and MUC16 is a useful adjunct in the diagnosis of pancreatic adenocarcinoma on fine-needle aspiration cytology.	MUC16 MUC4	1.90e-05	2	152	2	23544943
Pubmed	Expression of mucins in mucoid otitis media.	MUC5B MUC4	1.90e-05	2	152	2	14690056
Pubmed	Autophagy inhibition prevents lymphatic malformation progression to lymphangiosarcoma by decreasing osteopontin and Stat3 signaling.	TSC1 RB1CC1	1.90e-05	2	152	2	36813768
Pubmed	Functional and non-functional joining in immunoglobulin light chain genes of a mouse myeloma.	IGKV1-12 IGKV1D-12	1.90e-05	2	152	2	6776411
Pubmed	Variable region sequences of autoantibodies from mice with experimental systemic lupus erythematosus.	IGKV1-12 IGKV1D-12	1.90e-05	2	152	2	8325334
Pubmed	Nuclear Met promotes hepatocellular carcinoma tumorigenesis and metastasis by upregulation of TAK1 and activation of NF-κB pathway.	MET MAP3K7	1.90e-05	2	152	2	28989054
Pubmed	Expression of human endogenous retrovirus type K envelope glycoprotein in insect and mammalian cells.	ERVK-6 ERVK-19	1.90e-05	2	152	2	9060628
Pubmed	Evolutionary relationships within a subgroup of HERV-K-related human endogenous retroviruses.	ERVK-6 ERVK-19	1.90e-05	2	152	2	9460924
Pubmed	Mutation in the neuronal voltage-gated sodium channel SCN1A in familial hemiplegic migraine.	SCN1A SCN5A	1.90e-05	2	152	2	16054936
Pubmed	Comparative structural analysis of human Nav1.1 and Nav1.5 reveals mutational hotspots for sodium channelopathies.	SCN1A SCN5A	1.90e-05	2	152	2	33712547
Pubmed	Nkx3.2-induced suppression of Runx2 is a crucial mediator of hypoxia-dependent maintenance of chondrocyte phenotypes.	NKX3-2 RUNX2	1.90e-05	2	152	2	22093831
Pubmed	Cloning and characterization of 1116NS19.9 heavy and light chain cDNAs and expression of antibody fragments in Escherichia coli.	IGKV1-12 IGKV1D-12	1.90e-05	2	152	2	8372513
Pubmed	Identification of O-GlcNAc sites within peptides of the Tau protein and their impact on phosphorylation.	OGT MAPT	1.90e-05	2	152	2	21327254
Pubmed	Autophagic lipid metabolism sustains mTORC1 activity in TSC-deficient neural stem cells.	TSC1 RB1CC1	1.90e-05	2	152	2	32577608
Pubmed	Depletion of mTOR ameliorates CD4+ T cell pyroptosis by promoting autophagy activity in septic mice.	RICTOR TSC1	1.90e-05	2	152	2	37738689
Pubmed	Biallelic variants in HECT E3 paralogs, HECTD4 and UBE3C, encoding ubiquitin ligases cause neurodevelopmental disorders that overlap with Angelman syndrome.	HECTD4 UBE3C	1.90e-05	2	152	2	36401616
Pubmed	Microtubule-associated protein tau (Mapt) is expressed in terminally differentiated odontoblasts and severely down-regulated in morphologically disturbed odontoblasts of Runx2 transgenic mice.	MAPT RUNX2	1.90e-05	2	152	2	25707508
Pubmed	Possible prediction of the response of esophageal squamous cell carcinoma to neoadjuvant chemotherapy based on gene expression profiling.	MUC4 MUC20	1.90e-05	2	152	2	26673820
Pubmed	Mucin 20 modulates proteasome capacity through c-Met signalling to increase carfilzomib sensitivity in mantle cell lymphoma.	MET MUC20	1.90e-05	2	152	2	34651428
Pubmed	Advancing the understanding of autism disease mechanisms through genetics.	TSC1 NRXN1 SCN1A	2.27e-05	13	152	3	27050589
Pubmed	Large-scale characterization of HeLa cell nuclear phosphoproteins.	TRERF1 DIP2B MAPT RICTOR BRD3 BTAF1 NUP214 HUWE1 MED1 SETD2 MED13 TP53BP1 SON	3.82e-05	774	152	13	15302935
Pubmed	Defining the proximal interaction networks of Arf GTPases reveals a mechanism for the regulation of PLD1 and PI4KB.	DSC2 DSCAM MUC16 RICTOR HUWE1 MET NEO1 LIPE PI4KA UBAC2 RAPGEF2 MAP3K7 NOL8	3.98e-05	777	152	13	35844135
Pubmed	Dynamic Protein Interactions of the Polycomb Repressive Complex 2 during Differentiation of Pluripotent Cells.	CRYBG2 BRD3 NUP214 HUWE1 RB1CC1 RYBP KMT2C AEBP2 MUC4 TP53BP1	4.41e-05	469	152	10	27634302
Pubmed	The V kappa genes of the L regions and the repertoire of V kappa gene sequences in the human germ line.	IGKV1-17 IGKV1-12 IGKV1D-12	5.32e-05	17	152	3	8223863
Pubmed	Genetic determinants of P wave duration and PR segment.	MET SCN5A MED13	5.32e-05	17	152	3	24850809
Pubmed	Conditional Knockout of Neurexins Alters the Contribution of Calcium Channel Subtypes to Presynaptic Ca2+ Influx.	NRXN3 NRXN1	5.68e-05	3	152	2	38891114
Pubmed	Microbial products alter the expression of membrane-associated mucin and antimicrobial peptides in a three-dimensional human endocervical epithelial cell model.	MUC16 MUC4	5.68e-05	3	152	2	23053434
Pubmed	Immunoglobulin genes of the kappa light chain type from two human lymphoid cell lines are closely related.	IGKV1-39 IGKV1D-39	5.68e-05	3	152	2	6091049
Pubmed	Silencing of MUC20 suppresses the malignant character of pancreatic ductal adenocarcinoma cells through inhibition of the HGF/MET pathway.	MET MUC20	5.68e-05	3	152	2	29993037
Pubmed	Sox9 directly promotes Bapx1 gene expression to repress Runx2 in chondrocytes.	NKX3-2 RUNX2	5.68e-05	3	152	2	19306868
Pubmed	alpha-Neurexins are required for efficient transmitter release and synaptic homeostasis at the mouse neuromuscular junction.	NRXN3 NRXN1	5.68e-05	3	152	2	16406382
Pubmed	Identification of an active reverse transcriptase enzyme encoded by a human endogenous HERV-K retrovirus.	ERVK-6 ERVK-9	5.68e-05	3	152	2	9971820
Pubmed	The tumor suppressor Tsc1 enforces quiescence of naive T cells to promote immune homeostasis and function.	RICTOR TSC1	5.68e-05	3	152	2	21765414
Pubmed	Alternative Splicing of Presynaptic Neurexins Differentially Controls Postsynaptic NMDA and AMPA Receptor Responses.	NRXN3 NRXN1	5.68e-05	3	152	2	31005376
Pubmed	Loss of Fnip1 alters kidney developmental transcriptional program and synergizes with TSC1 loss to promote mTORC1 activation and renal cyst formation.	TSC1 FNIP1	5.68e-05	3	152	2	29897930
Pubmed	Regulated Dynamic Trafficking of Neurexins Inside and Outside of Synaptic Terminals.	NRXN3 NRXN1	5.68e-05	3	152	2	26446217
Pubmed	Analysis of the human neurexin genes: alternative splicing and the generation of protein diversity.	NRXN3 NRXN1	5.68e-05	3	152	2	11944992
Pubmed	Nutritional and metabolic control of germ cell fate through O-GlcNAc regulation.	OGT DDX4	5.68e-05	3	152	2	37842859
Pubmed	Alternative splicing of neurexins 1-3 is modulated by neuroinflammation in the prefrontal cortex of a murine model of multiple sclerosis.	NRXN3 NRXN1	5.68e-05	3	152	2	33058888
Pubmed	Important contribution of alpha-neurexins to Ca2+-triggered exocytosis of secretory granules.	NRXN3 NRXN1	5.68e-05	3	152	2	17035546
Pubmed	Functional Consequences of Differential O-glycosylation of MUC1, MUC4, and MUC16 (Downstream Effects on Signaling).	MUC16 MUC4	5.68e-05	3	152	2	27483328
Pubmed	Neurexins: three genes and 1001 products.	NRXN3 NRXN1	5.68e-05	3	152	2	9448462
Pubmed	MicroRNA-200c modulates the expression of MUC4 and MUC16 by directly targeting their coding sequences in human pancreatic cancer.	MUC16 MUC4	5.68e-05	3	152	2	24204560
Pubmed	Deletion of α-neurexin II results in autism-related behaviors in mice.	NRXN3 NRXN1	5.68e-05	3	152	2	25423136
Pubmed	Rare variants in the genetic background modulate cognitive and developmental phenotypes in individuals carrying disease-associated variants.	NRXN1 SETD5	5.68e-05	3	152	2	30190612
Pubmed	mTORC2 Promotes Tumorigenesis via Lipid Synthesis.	RICTOR TSC1	5.68e-05	3	152	2	29232555
Pubmed	T-cell-specific mTOR deletion in mice ameliorated CD4+ T-cell survival in lethal sepsis induced by severe invasive candidiasis.	RICTOR TSC1	5.68e-05	3	152	2	31668132
Pubmed	Expression of the transmembrane mucins, MUC1, MUC4 and MUC16, in normal endometrium and in endometriosis.	MUC16 MUC4	5.68e-05	3	152	2	24939955
Pubmed	Endogenous β-neurexins on axons and within synapses show regulated dynamic behavior.	NRXN3 NRXN1	5.68e-05	3	152	2	34133920
Pubmed	mTOR masters monocytic myeloid-derived suppressor cells in mice with allografts or tumors.	RICTOR TSC1	5.68e-05	3	152	2	26833095
Pubmed	Expression of mucin (MUC) genes in mucoepidermoid carcinoma.	MUC19 MUC4	5.68e-05	3	152	2	21072847
Pubmed	UDP-N-acetylglucosaminyl transferase (OGT) in brain tissue: temperature sensitivity and subcellular distribution of cytosolic and nuclear enzyme.	OGT MAPT	5.68e-05	3	152	2	12911634
Pubmed	DUSP28 links regulation of Mucin 5B and Mucin 16 to migration and survival of AsPC-1 human pancreatic cancer cells.	MUC16 MUC5B	5.68e-05	3	152	2	27230679
Interaction	YWHAH interactions	DIP2B OGT EMC1 DSC2 MAPT ARHGEF5 NCKIPSD HECTD4 MAGI3 RICTOR TSC1 HUWE1 RB1CC1 MED1 MAST2 NCKAP5L PLEKHG5 MADD CEP170 ZCCHC14 PLEKHG1 PLEKHG3 PI4KA NAV2 FNIP1 RAPGEF2 MAP3K7 HECTD1 TMCC1	3.59e-10	1102	139	29	int:YWHAH
Interaction	FBXO22 interactions	IGKV1-39 IGKV1-33 IGKV1-27 IGKV1-17 IGKV1-16 PCDHB6 TSC1 BRD3 NUP214 KMT2C NAV2 PHLPP1 RP1 TAF4 IGKV1D-39 IGKV1D-33 IGKV1D-16 MUC4 TP53BP1	5.95e-09	540	139	19	int:FBXO22
Interaction	YWHAG interactions	IGKV1-12 OGT DSC2 MAPT ARHGEF5 NCKIPSD HECTD4 MAGI3 RICTOR TSC1 HUWE1 RB1CC1 MAST2 NCKAP5L PLEKHG5 ITPKB CEP170 PLEKHG1 PLEKHG3 PI4KA NAV2 FNIP1 PPIP5K1 RAPGEF2 HECTD1 TMCC1 SON	9.80e-08	1248	139	27	int:YWHAG
Interaction	YWHAB interactions	OGT EMC1 DSC2 MAPT ARHGEF5 NCKIPSD HECTD4 RICTOR TSC1 RB1CC1 MAST2 NCKAP5L PLEKHG5 ITPKB CEP170 PLEKHG3 NAV2 RAPGEF2 HECTD1 TMCC1 SON	6.21e-06	1014	139	21	int:YWHAB
Interaction	TOP3B interactions	CRYBG2 WDR70 HECTD4 ADGRL1 BTAF1 NUP214 HUWE1 MAST2 PLEKHG5 MADD ZCCHC14 PLEKHG1 KMT2C SETD5 PI4KA TTLL4 SCN5A MIB1 NAV2 HMGXB3 GPC2 UBE3C KLHL14 HECTD1 MED13 TP53BP1	7.57e-06	1470	139	26	int:TOP3B
Interaction	YWHAZ interactions	OGT DSC2 MAPT ARHGEF5 NCKIPSD HECTD4 RICTOR TSC1 BRD3 HUWE1 RB1CC1 MAST2 NCKAP5L PLEKHG5 MADD CEP170 NRXN1 PLEKHG3 NAV2 RAPGEF2 HECTD1 TMCC1 TP53BP1	3.44e-05	1319	139	23	int:YWHAZ
Interaction	MGA interactions	CRYBG2 FOS RICTOR BRD3 CDH19 RYBP LHX2 MIB1 TP53BP1	4.44e-05	240	139	9	int:MGA
Cytoband	2p12	IGKV1-39 IGKV1-33 IGKV1-27 IGKV1-17 IGKV1-16 IGKV1-12 IGKV1-6 GGCX IGKV1-5 IGKV1D-39 IGKV1D-33 IGKV1D-16 IGKV1D-12	1.44e-16	117	151	13	2p12
Cytoband	Ensembl 112 genes in cytogenetic band chr2p11	IGKV1-39 IGKV1-33 IGKV1-27 IGKV1-17 IGKV1-16 IGKV1-12 IGKV1-6 GGCX IGKV1-5 IGKV1D-39 IGKV1D-33 IGKV1D-16 IGKV1D-12	3.64e-13	213	151	13	chr2p11
Cytoband	8p23.1	FAM90A17 FAM90A19 FAM90A7 FAM90A18 FAM90A9 FAM90A8 FAM90A16 FAM90A10	4.94e-08	154	151	8	8p23.1
Cytoband	Ensembl 112 genes in cytogenetic band chr8p23	FAM90A17 FAM90A19 FAM90A7 FAM90A18 FAM90A9 FAM90A8 FAM90A16 FAM90A10	1.20e-06	234	151	8	chr8p23
GeneFamily	Immunoglobulin kappa locus at 2p11.2	IGKV1-39 IGKV1-33 IGKV1-27 IGKV1-17 IGKV1-16 IGKV1-12 IGKV1-6 IGKV1-5 IGKV1D-39 IGKV1D-33 IGKV1D-16 IGKV1D-12	3.29e-14	83	101	12	351
GeneFamily	CD molecules\|Mucins	MUC19 MUC16 MUC5B MUC12 MUC17 MUC22 MUC4 MUC20	1.37e-13	21	101	8	648
GeneFamily	Sodium voltage-gated channel alpha subunits	SCN1A SCN5A	1.08e-03	9	101	2	1203
GeneFamily	CD molecules\|Type II classical cadherins	CDH19 CDH5	2.32e-03	13	101	2	1186
Coexpression	NABA_ECM_AFFILIATED	MUC19 MUC16 MUC5B MUC12 MUC17 GPC2 MUC22 MUC4 MUC20	3.48e-07	170	140	9	M5880
Coexpression	DACOSTA_UV_RESPONSE_VIA_ERCC3_DN	OGT BAZ2B BTAF1 NECTIN3 RB1CC1 MED1 MAST2 CEP170 RYBP SETD2 PHLPP1 TAF4 RAPGEF2 TMCC1 MED13 TP53BP1 SON	3.40e-06	856	140	17	M4500
Coexpression	RASHI_RESPONSE_TO_IONIZING_RADIATION_6	IGKV1-39 IGKV1-27 IGKV1-12 IGKV1-5 IGKV1D-39 IGKV1D-33 IGKV1D-12	7.21e-06	132	140	7	MM996
Coexpression	GSE21063_CTRL_VS_ANTI_IGM_STIM_BCELL_NFATC1_KO_3H_DN	CCNL2 BAZ2B FOS HECTD4 ZCCHC14 SETD2 TMCC1 MED13	8.36e-06	189	140	8	M8275
Coexpression	CUI_TCF21_TARGETS_2_DN	MKRN4P SLC12A6 MAPT HLX RICTOR BTAF1 NECTIN3 ITPKB PLEKHG1 KMT2C PDE4DIP PHLPP1 RAPGEF2 CDH5 MED13 SON	2.23e-05	888	140	16	MM1018
Coexpression	NABA_ECM_AFFILIATED	MUC19 MUC16 MUC5B MUC17 GPC2 MUC4 MUC20	2.32e-05	158	140	7	MM17063
Coexpression	MANNO_MIDBRAIN_NEUROTYPES_HGABA	AKAP6 DIP2B CACNB4 DSCAM MUC19 MAGI3 ADGRL1 RICTOR RB1CC1 NRXN3 NRXN1 PLPPR4 SCN1A PDE4DIP CAPRIN2 ANKIB1 GPC2 KLHL14	2.58e-05	1106	140	18	M39071
Coexpression	BUYTAERT_PHOTODYNAMIC_THERAPY_STRESS_UP	ZNF473 BAZ2B FOS DLGAP4 TSC1 RB1CC1 AREG RYBP ZCCHC14 SETD2 SETD5 PDE4DIP NAV2 TMCC1 PDZD2	3.54e-05	822	140	15	M6782
Coexpression	MURARO_PANCREAS_BETA_CELL	MAPT DLGAP4 HECTD4 NECTIN3 HUWE1 MADD ZCCHC14 KMT2C NEO1 PI4KA PDE4DIP NAV2 FNIP1 UBE3C HECTD1 PDZD2	4.76e-05	946	140	16	M39169
Coexpression	CUI_TCF21_TARGETS_2_DN	SLC12A6 MAPT HLX RICTOR BTAF1 NECTIN3 ITPKB PLEKHG1 KMT2C PDE4DIP PHLPP1 RAPGEF2 CDH5 MED13 SON	5.45e-05	854	140	15	M1533
Coexpression	GSE29617_DAY3_VS_DAY7_TIV_FLU_VACCINE_PBMC_2008_DN	CCNL2 SLC12A6 OGT BTAF1 HMGXB3 KLHL14 HECTD1	7.76e-05	191	140	7	M4935
Coexpression	SALVADOR_MARTIN_PEDIATRIC_TBD_ANTI_TNF_THERAPY_NONRESPONDER_POST_TREATMENT_DN	IGKV1-39 IGKV1-12 IGKV1-5	7.94e-05	16	140	3	M41742
Coexpression	DACOSTA_UV_RESPONSE_VIA_ERCC3_TTD_DN	BTAF1 NECTIN3 RB1CC1 TMCC1 SON	8.90e-05	84	140	5	M13008
Coexpression	MANNO_MIDBRAIN_NEUROTYPES_HDA	DSCAM KCTD8 MUC19 MUC16 MAST2 NRXN3 NRXN1 PLPPR4 PDE4DIP GPC2 KLHL14	9.01e-05	506	140	11	M39067
Coexpression	GSE3982_MEMORY_CD4_TCELL_VS_TH1_UP	ADGRL1 TSC1 BRD3 SETD2 PLEKHG3 CAPRIN2 SON	9.42e-05	197	140	7	M5378
Coexpression	GSE8921_UNSTIM_0H_VS_TLR1_2_STIM_MONOCYTE_3H_DN	PPP1R3A RYBP PLEKHG3 SCN1A SYPL2 PHLPP1 UBAC2	1.03e-04	200	140	7	M6399
Coexpression	GSE27786_LIN_NEG_VS_CD8_TCELL_DN	CCNL2 NRXN1 TEX264 PI4KA PDE4DIP AEBP2 ANKIB1	1.03e-04	200	140	7	M4777
Coexpression	NAKAYA_PBMC_FLUARIX_FLUVIRIN_AGE_18_50YO_3DY_DN	CCNL2 DIP2B OGT RICTOR RUNX2 ITPKB FNIP1 SPRTN RAPGEF2 SON	1.14e-04	432	140	10	M41149
Coexpression	MCDOWELL_ACUTE_LUNG_INJURY_DN	OGT MAPT PDE4DIP C5	1.16e-04	47	140	4	M1650
ToppCell	Parenchymal-10x5prime-Immune_Lymphocytic-B\|10x5prime / Cell types per location group and 10X technology with lineage, and cell group designations	IGKV1-39 IGKV1-33 IGKV1-27 IGKV1-17 IGKV1-16 IGKV1-12 IGKV1-6 IGKV1-5 IGKV1D-39 KLHL14 IGKV1D-33 IGKV1D-16 IGKV1D-12	7.06e-14	197	141	13	9fe1b757f76c2d43d39aa9ac500eaba98723985c
ToppCell	5'-Adult-LargeIntestine-Hematopoietic-Plasma_cells\|Adult / Celltypes from developing, pediatric, Crohn's, & adult GI tract	IGKV1-39 IGKV1-27 IGKV1-17 IGKV1-16 IGKV1-12 IGKV1-6 RUNX2 IGLV3-10 IGKV1-5 IGKV1D-39 IGKV1D-16 IGKV1D-12	1.12e-12	190	141	12	79ee6d10dfbb775da149a1104da5823cf63bbb46
ToppCell	5'-Adult-LargeIntestine-Hematopoietic-Plasma_cells-IgA_plasma_cell\|Adult / Celltypes from developing, pediatric, Crohn's, & adult GI tract	IGKV1-39 IGKV1-27 IGKV1-17 IGKV1-16 IGKV1-12 IGKV1-6 RUNX2 IGLV3-10 IGKV1-5 IGKV1D-39 IGKV1D-16 IGKV1D-12	1.12e-12	190	141	12	18762ce78ed0b206ade19e1c8ff76a2647489f68
ToppCell	Parenchymal-10x5prime-Immune_Lymphocytic-B-B_plasma-B_plasma_IgG\|10x5prime / Cell types per location group and 10X technology with lineage, and cell group designations	IGKV1-39 IGKV1-33 IGKV1-27 IGKV1-17 IGKV1-16 IGKV1-12 IGKV1-6 IGKV1-5 IGKV1D-39 IGKV1D-33 IGKV1D-16 IGKV1D-12	1.53e-12	195	141	12	f3f7f1a77a1edd2b50a8211c76fe289738eb04cf
ToppCell	Bronchial-10x5prime-Immune_Lymphocytic-B-B_plasma-B_plasma_IgG\|10x5prime / Cell types per location group and 10X technology with lineage, and cell group designations	IGKV1-39 IGKV1-33 IGKV1-27 IGKV1-17 IGKV1-16 IGKV1-12 IGKV1-6 IGKV1-5 IGKV1D-39 IGKV1D-33 IGKV1D-16 IGKV1D-12	1.62e-12	196	141	12	fec21383435779bf4c632decd3d29c6ca7baebfb
ToppCell	IPF-Lymphoid-B_Plasma\|IPF / Disease state, Lineage and Cell class	IGKV1-39 IGKV1-33 IGKV1-17 IGKV1-12 IGKV1-6 IGLV3-10 IGKV1-5 IGKV1D-39 IGKV1D-33 IGKV1D-16 IGKV1D-12	1.13e-11	176	141	11	e4f33f6cd140dd4fa3002bcd65ac8005d27865d1
ToppCell	PBMC-Control-Lymphocyte-B-Plasmablast-Plasmablast-Plasmablast\|Control / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.01)	IGKV1-39 IGKV1-33 IGKV1-17 IGKV1-16 IGKV1-6 IGLV3-10 IGKV1-5 IGKV1D-39 KLHL14 IGKV1D-16 IGKV1D-12	1.36e-11	179	141	11	494febe77c6d4e6a2c6f0928bbf4c84b0301f188
ToppCell	Bronchial-10x5prime-Immune_Lymphocytic-B-B_plasma\|10x5prime / Cell types per location group and 10X technology with lineage, and cell group designations	IGKV1-39 IGKV1-33 IGKV1-27 IGKV1-16 IGKV1-12 IGKV1-6 IGKV1-5 IGKV1D-39 IGKV1D-33 IGKV1D-16 IGKV1D-12	3.63e-11	196	141	11	c38e7f533c619afe008de0e99042f7180c2da918
ToppCell	Biopsy_IPF-Immune-Plasma_cells\|Biopsy_IPF / Sample group, Lineage and Cell type	IGKV1-39 IGKV1-27 IGKV1-17 IGKV1-16 IGKV1-12 IGKV1-6 IGLV3-10 IGKV1-5 IGKV1D-39 IGKV1D-33 IGKV1D-16	3.63e-11	196	141	11	a1b6a8000b86efcb07843998aa3a49bb1f54bcda
ToppCell	COPD-Lymphoid-B_Plasma\|World / Disease state, Lineage and Cell class	IGKV1-39 IGKV1-27 IGKV1-17 IGKV1-16 IGKV1-12 IGLV3-10 IGKV1-5 IGKV1D-39 IGKV1D-33 IGKV1D-16	2.43e-10	175	141	10	d73ee324479172501481b54967a0f3bd870fcf3a
ToppCell	Control-Lymphoid_P-Plasmablast\|Control / Disease group, lineage and cell class	IGKV1-33 IGKV1-27 IGKV1-17 IGKV1-16 IGKV1-6 IGKV1-5 IGKV1D-39 KLHL14 IGKV1D-16 IGKV1D-12	2.57e-10	176	141	10	4b4416f342b732d2cc60133838728880326257d8
ToppCell	Control-Lymphoid_P\|Control / Disease group, lineage and cell class	IGKV1-33 IGKV1-27 IGKV1-17 IGKV1-16 IGKV1-6 IGKV1-5 IGKV1D-39 KLHL14 IGKV1D-16 IGKV1D-12	2.57e-10	176	141	10	d895a6b295cd649273ff80ad7785a3e0ae4c728a
ToppCell	10x5'-Lung-Lymphocytic_B\|Lung / Manually curated celltypes from each tissue	IGKV1-39 IGKV1-16 IGKV1-12 IGLV3-10 PLEKHG1 IGKV1-5 IGKV1D-39 KLHL14 IGKV1D-33 IGKV1D-12	3.57e-10	182	141	10	310f94437d197eaaaf6e30e68063b33e94befe77
ToppCell	5'-Adult-LargeIntestine-Hematopoietic\|Adult / Celltypes from developing, pediatric, Crohn's, & adult GI tract	IGKV1-39 IGKV1-27 IGKV1-17 IGKV1-16 IGKV1-6 RUNX2 IGLV3-10 IGKV1-5 IGKV1D-39 IGKV1D-16	5.72e-10	191	141	10	d1d30279ed4612b4f62c225d9eabf0b8a7a09d11
ToppCell	Parenchymal-10x5prime-Immune_Lymphocytic-B-B_plasma\|10x5prime / Cell types per location group and 10X technology with lineage, and cell group designations	IGKV1-39 IGKV1-27 IGKV1-17 IGKV1-16 IGKV1-12 IGKV1-6 IGKV1-5 IGKV1D-39 IGKV1D-16 IGKV1D-12	6.66e-10	194	141	10	6ef4aeb8d8e35e4df58ff2a8256caa2113291de9
ToppCell	Bronchial-10x5prime-Immune_Lymphocytic-B-B_plasma-B_plasma_IgA\|10x5prime / Cell types per location group and 10X technology with lineage, and cell group designations	IGKV1-39 IGKV1-33 IGKV1-16 IGKV1-12 IGKV1-6 PPP1R3A IGKV1-5 IGKV1D-39 IGKV1D-33 IGKV1D-16	7.00e-10	195	141	10	13f4ee21568fd747608412d33559d10561dbb3c8
ToppCell	Tracheal-10x5prime-Immune_Lymphocytic-B\|10x5prime / Cell types per location group and 10X technology with lineage, and cell group designations	IGKV1-39 IGKV1-33 IGKV1-17 IGKV1-16 IGKV1-12 IGKV1-6 IGKV1D-39 KLHL14 IGKV1D-33 IGKV1D-12	7.73e-10	197	141	10	2662138671262b30508c5759038bcdcfe6551696
ToppCell	BAL-Mild-Lymphocyte-B\|Mild / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.01)	IGKV1-39 IGKV1-16 IGKV1-12 IGKV1-6 IGLV3-10 PLEKHG1 IGKV1-5 IGKV1D-39 IGKV1D-12	3.68e-09	169	141	9	307571e57c3bfdf15f0fe1a8b36585e8e4f8a207
ToppCell	BAL-Mild-Lymphocyte-B-B_cell-B_cell-B_activate-7\|Mild / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.01)	IGKV1-39 IGKV1-16 IGKV1-12 IGKV1-6 IGLV3-10 PLEKHG1 IGKV1-5 IGKV1D-39 IGKV1D-12	3.87e-09	170	141	9	ee2ee67d90ae4596de8ccd620e37c82cf51651d4
ToppCell	BAL-Mild-Lymphocyte-B-B_cell-B_cell\|Mild / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.01)	IGKV1-39 IGKV1-16 IGKV1-12 IGKV1-6 IGLV3-10 PLEKHG1 IGKV1-5 IGKV1D-39 IGKV1D-12	3.87e-09	170	141	9	d7ca0c6ce5d2b7de99346f87e07aa7fe728fa08a
ToppCell	BAL-Mild-Lymphocyte-B-B_cell\|Mild / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.01)	IGKV1-39 IGKV1-16 IGKV1-12 IGKV1-6 IGLV3-10 PLEKHG1 IGKV1-5 IGKV1D-39 IGKV1D-12	3.87e-09	170	141	9	52787f6d529c285d9f0c04cc022710ead5b89b3f
ToppCell	(2)_Plasma_cells\|World / Lung cell shreds - cell class (v4) and cell subclass (v4)	IGKV1-39 IGKV1-17 IGKV1-12 IGKV1-6 IGLV3-10 IGKV1-5 IGKV1D-39 KLHL14 IGKV1D-16	5.51e-09	177	141	9	ed3c936bb69f9bc7291b4f6cde1d204078117c48
ToppCell	PBMC-Control-Lymphocyte-B-Plasmablast\|Control / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.01)	IGKV1-17 IGKV1-16 IGKV1-6 IGLV3-10 IGKV1-5 IGKV1D-39 KLHL14 IGKV1D-16 IGKV1D-12	6.08e-09	179	141	9	837ed81f18257f444eaeadc4fac89deedd4e3061
ToppCell	PBMC-Control-Lymphocyte-B-Plasmablast-Plasmablast\|Control / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.01)	IGKV1-17 IGKV1-16 IGKV1-6 IGLV3-10 IGKV1-5 IGKV1D-39 KLHL14 IGKV1D-16 IGKV1D-12	6.08e-09	179	141	9	b6ee4f41d8fb5f047b7bdd8489dda0a89fc6d43f
ToppCell	5'-Parenchyma_lung-Immune_Lymphocytic-Lymphocytic_B-plasma_cell-Plasma_cells-Plasma_cells_L.1.7.1.1\|5' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5	IGKV1-39 IGKV1-33 IGKV1-12 IGLV3-10 IGKV1-5 IGKV1D-39 IGKV1D-33 IGKV1D-16 IGKV1D-12	6.39e-09	180	141	9	e3877f6ef5f54ff689058b4c996ab1851822f871
ToppCell	Mild-Lymphoid-B\|Mild / Condition, Lineage, Cell class and cell subclass	IGKV1-39 IGKV1-33 IGKV1-27 IGKV1-16 IGKV1-12 IGKV1-6 PLEKHG1 IGKV1-5 IGKV1D-39	7.38e-09	183	141	9	9b64d2d143525e6f48a191facfd101462ff36324
ToppCell	Mild-Lymphoid-B-\|Mild / Condition, Lineage, Cell class and cell subclass	IGKV1-39 IGKV1-33 IGKV1-27 IGKV1-16 IGKV1-12 IGKV1-6 PLEKHG1 IGKV1-5 IGKV1D-39	7.38e-09	183	141	9	b5740f05a4dcdbbf24f7bf7a3f57ac01a5e75f60
ToppCell	3'-Parenchyma_lung-Immune_Lymphocytic-Lymphocytic_B-plasma_cell-Plasma_cells-Plasma_cells_L.1.7.0.0\|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5	IGKV1-39 IGKV1-17 IGKV1-16 IGKV1-12 IGKV1-6 IGLV3-10 IGKV1-5 IGKV1D-39 IGKV1D-33	7.38e-09	183	141	9	cf5c98f451a568308c52da5c926543dd4836c6b2
ToppCell	5'-Parenchyma_lung-Immune_Lymphocytic-Lymphocytic_B-plasma_cell-Plasma_cells\|5' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5	IGKV1-39 IGKV1-17 IGKV1-12 IGKV1-5 IGKV1D-39 KLHL14 IGKV1D-33 IGKV1D-16 IGKV1D-12	8.11e-09	185	141	9	08bc817908076734d66f2805cb954141f2cc5a18
ToppCell	5'-Parenchyma_lung-Immune_Lymphocytic-Lymphocytic_B-plasma_cell\|5' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5	IGKV1-39 IGKV1-17 IGKV1-12 IGKV1-5 IGKV1D-39 KLHL14 IGKV1D-33 IGKV1D-16 IGKV1D-12	8.11e-09	185	141	9	1704a12153a9b107bf03ecccd1a036cf61334d7a
ToppCell	healthy_donor-Lymphocytic-Plasma_cell-IgA_Plasmablast\|healthy_donor / Disease condition, Lineage, Cell class and subclass	IGKV1-33 IGKV1-27 IGKV1-17 IGKV1-6 IGKV1-5 IGKV1D-39 KLHL14 IGKV1D-16 IGKV1D-12	8.50e-09	186	141	9	e2c050ba02e1f84f0b7258dc92e7ff6ab349ff67
ToppCell	10x_3'_v3-bone_marrow_(10x_3'_v3)-lymphocytic-B_lymphocytic-plasma_cell\|bone_marrow_(10x_3'_v3) / Per Platform+tissue_group, by lineage_subgroup, cell_group, cell_type	IGKV1-39 IGKV1-17 IGKV1-16 IGKV1-6 C11orf24 IGKV1-5 IGKV1D-39 IGKV1D-33 IGKV1D-16	9.77e-09	189	141	9	5a42be62552d912d0abf68f00d75ac80bbd69f2c
ToppCell	Parenchymal-10x5prime-Immune_Lymphocytic-B-B_plasma-B_plasma_IgA\|10x5prime / Cell types per location group and 10X technology with lineage, and cell group designations	IGKV1-27 IGKV1-17 IGKV1-16 IGKV1-12 IGKV1-6 IGKV1-5 IGKV1D-39 IGKV1D-16 IGKV1D-12	1.17e-08	193	141	9	34f6c13884fdf7f8a87f942fcb36a58cfac3f65d
ToppCell	Parenchymal-10x3prime_v2-Immune_Lymphocytic-B-B_plasma-B_plasma_IgG\|10x3prime_v2 / Cell types per location group and 10X technology with lineage, and cell group designations	IGKV1-39 IGKV1-17 IGKV1-16 IGKV1-12 IGLV3-10 IGKV1-5 IGKV1D-39 IGKV1D-33 IGKV1D-16	1.28e-08	195	141	9	2d18f08f33f3b261c77b8adf87d1a184cc6d7400
ToppCell	Biopsy_Other_PF-Immune-Plasma_cells\|Biopsy_Other_PF / Sample group, Lineage and Cell type	IGKV1-39 IGKV1-27 IGKV1-16 IGKV1-12 IGKV1-6 IGKV1-5 IGKV1D-39 IGKV1D-33 IGKV1D-16	1.28e-08	195	141	9	d0305c6a68c9e361507b04db94f86873085d49b3
ToppCell	Tracheal-10x5prime-Immune_Lymphocytic-B-B_plasma-B_plasma_IgA\|10x5prime / Cell types per location group and 10X technology with lineage, and cell group designations	IGKV1-39 IGKV1-27 IGKV1-17 IGKV1-16 IGKV1-12 IGKV1-6 IGKV1D-39 KLHL14 IGKV1D-12	1.28e-08	195	141	9	df009b18898c10686f75cf72b4ec0eff18f5bb50
ToppCell	COVID_non-vent-Lymphocytic-Plasma_cell-IgG_Plasmablast\|COVID_non-vent / Disease condition, Lineage, Cell class and subclass	IGKV1-39 IGKV1-33 IGKV1-27 IGKV1-17 IGKV1-12 IGKV1-5 IGKV1D-39 KLHL14 IGKV1D-33	1.40e-08	197	141	9	b754fad4f3caae6de95df901fd96ea8697fe41b1
ToppCell	normal_Lung-B_lymphocytes-MALT_B_cells\|normal_Lung / Location, Cell class and cell subclass	IGKV1-39 IGKV1-16 IGKV1-12 IGKV1-6 IGKV1-5 IGKV1D-39 KLHL14 IGKV1D-33	4.33e-08	159	141	8	fbd0131b66f4267f7b0d6c3ad874ad097b859074
ToppCell	tumor_Lymph_Node_/_Brain-B_lymphocytes-MALT_B_cells\|tumor_Lymph_Node_/_Brain / Location, Cell class and cell subclass	IGKV1-27 IGKV1-17 IGKV1-16 IGKV1-12 IGKV1-6 IGKV1-5 IGKV1D-39 IGKV1D-33	4.33e-08	159	141	8	204e5a675f4684c9570c24c8d34bbf632fd8164a
ToppCell	368C-Lymphocytic-Plasma_cell-\|368C / Donor, Lineage, Cell class and subclass (all cells)	IGKV1-39 IGKV1-17 IGKV1-12 IGKV1-6 IGLV3-10 IGKV1-5 IGKV1D-39 IGKV1D-12	5.01e-08	162	141	8	c21a54310b239d999bbc9d8fb5e8fda16e0bc336
ToppCell	368C-Lymphocytic-Plasma_cell\|368C / Donor, Lineage, Cell class and subclass (all cells)	IGKV1-39 IGKV1-17 IGKV1-12 IGKV1-6 IGLV3-10 IGKV1-5 IGKV1D-39 IGKV1D-12	5.01e-08	162	141	8	f945688815229c8386cbcbf46deee7df316fa8d3
ToppCell	10x5'-GI_large-bowel\|World / Manually curated celltypes from each tissue	IGKV1-39 IGKV1-16 IGKV1-12 IGKV1-6 IGKV1-5 IGKV1D-39 IGKV1D-33 IGKV1D-16	6.64e-08	168	141	8	1290c909655bc37f6b8bf216d18127a21b99e9c0
ToppCell	5'-Parenchyma_lung-Immune_Lymphocytic-Lymphocytic_B-plasma_cell-Plasma_cells-Plasma_cells_L.1.7.0.0\|5' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5	IGKV1-39 IGKV1-27 IGKV1-16 IGKV1-12 IGKV1-6 IGKV1D-39 KLHL14 IGKV1D-33	8.32e-08	173	141	8	7e6bfe85f60834f317941b70d6e0dc3bd527d293
ToppCell	metastatic_Brain-B_lymphocytes-MALT_B_cells\|metastatic_Brain / Location, Cell class and cell subclass	IGKV1-39 IGKV1-27 IGKV1-17 IGKV1-12 IGKV1-6 IGKV1-5 IGKV1D-39 IGKV1D-12	9.50e-08	176	141	8	50e207403d48ce1b55a78897adb5519a2430a626
ToppCell	PBMC-Control-Lymphocyte-B-Plasmablast-Plasmablast-\|Control / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.09)	IGKV1-17 IGKV1-16 IGKV1-6 IGLV3-10 IGKV1-5 KLHL14 IGKV1D-16 IGKV1D-12	9.93e-08	177	141	8	4c434a7b7cc54cf4dac996bbc3f5124d9ef9a9cd
ToppCell	PBMC-Control-Lymphocyte-B-Plasmablast-Plasmablast\|Control / Location, Disease Group, Cell group, Cell class (2021.03.09)	IGKV1-17 IGKV1-16 IGKV1-6 IGLV3-10 IGKV1-5 KLHL14 IGKV1D-16 IGKV1D-12	9.93e-08	177	141	8	d746122bf8d208c3aa4d156e8c12d0a0e555c6e5
ToppCell	PBMC-Control-Lymphocyte-B-Plasmablast\|Control / Location, Disease Group, Cell group, Cell class (2021.03.09)	IGKV1-17 IGKV1-16 IGKV1-6 IGLV3-10 IGKV1-5 KLHL14 IGKV1D-16 IGKV1D-12	9.93e-08	177	141	8	fc40918825b7e1eb6861df59dfca944778a64b98
ToppCell	Healthy-Plasmablast\|Healthy / disease group, cell group and cell class	IGKV1-27 IGKV1-16 IGLV3-10 IGKV1-5 IGKV1D-39 KLHL14 IGKV1D-33 IGKV1D-16	9.93e-08	177	141	8	4ff75c609ac9edf7a94bda42eb7124c559e8b6aa
ToppCell	normal_Lymph_Node-B_lymphocytes-Plasma_cells\|normal_Lymph_Node / Location, Cell class and cell subclass	IGKV1-27 IGKV1-17 IGKV1-12 IGKV1-6 IGLV3-10 IGKV1-5 IGKV1D-39 IGKV1D-12	1.18e-07	181	141	8	949ac3b60e7fb5968da4c4e872965fb4e10f4a35
ToppCell	BAL-Mild-Lymphocyte-B-B_cell-B_cell\|Mild / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.09)	IGKV1-39 IGKV1-16 IGKV1-12 IGKV1-6 IGLV3-10 PLEKHG1 IGKV1-5 IGKV1D-39	1.34e-07	184	141	8	3f8a359e40bebe58545f708682e5e5d1b70cf5cb
ToppCell	BAL-Mild-Lymphocyte-B-B_cell-B_cell-\|Mild / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.09)	IGKV1-39 IGKV1-16 IGKV1-12 IGKV1-6 IGLV3-10 PLEKHG1 IGKV1-5 IGKV1D-39	1.34e-07	184	141	8	64bede8db709fd32f40c03265b96f0b12155bb8a
ToppCell	BAL-Mild-Lymphocyte-B-B_cell\|Mild / Location, Disease Group, Cell group, Cell class (2021.03.09)	IGKV1-39 IGKV1-16 IGKV1-12 IGKV1-6 IGLV3-10 PLEKHG1 IGKV1-5 IGKV1D-39	1.39e-07	185	141	8	609080adb2cfb105bb7b8efb617553833299f371
ToppCell	kidney_cells-Renal_AKI_(acute_kidney_injury)-Immune-Lymphocytic_B-Plasma_Cell-\|Renal_AKI_(acute_kidney_injury) / Celltypes from Cells and Nuclei per compartment and clinical group	IGKV1-39 IGKV1-27 IGKV1-17 IGKV1-16 IGKV1-6 IGKV1-5 IGKV1D-39 IGKV1D-33	1.39e-07	185	141	8	0fff2608f507e019ebb69c27e58fd5be3b049bef
ToppCell	kidney_cells-Renal_AKI_(acute_kidney_injury)-Immune-Lymphocytic_B-Plasma_Cell\|Renal_AKI_(acute_kidney_injury) / Celltypes from Cells and Nuclei per compartment and clinical group	IGKV1-39 IGKV1-27 IGKV1-17 IGKV1-16 IGKV1-6 IGKV1-5 IGKV1D-39 IGKV1D-33	1.39e-07	185	141	8	79edc1eeb7b5b9123961ac3ecf398ee68d9dddb9
ToppCell	IPF-Lymphoid-B_Plasma\|Lymphoid / Disease state, Lineage and Cell class	IGKV1-39 IGKV1-17 IGKV1-12 IGKV1-5 ZNF608 IGKV1D-39 IGKV1D-33 IGKV1D-12	1.45e-07	186	141	8	f9c21daf905d0bb0e0e769ca4bb069ea4b1ba25b
ToppCell	Mild_COVID-19-B_cell-B_cell\|Mild_COVID-19 / Disease group,lineage and cell class （2021.01.30）	IGKV1-39 IGKV1-17 IGKV1-16 IGKV1-6 IGLV3-10 PLEKHG1 IGKV1-5 IGKV1D-39	1.45e-07	186	141	8	855a5a00ba2aa1b5c63b8db56d026ddecc546050
ToppCell	10x5'-GI_small-bowel-Lymphocytic_T_CD4-T_CD4/CD8\|GI_small-bowel / Manually curated celltypes from each tissue	RICTOR BTAF1 HUWE1 RB1CC1 KMT2C RAPGEF2 MED13 TP53BP1	1.58e-07	188	141	8	ab9b725d6e0cdab8e9ddda6dee09e14730e9a578
ToppCell	Epithelial-club_cell\|World / Lineage, Cell type, age group and donor	MAGI3 PLEKHG1 MET NRXN3 ZNF608 NAV2 RP1 MUC4	1.93e-07	193	141	8	2bdd09004fa433550958ec42ba4b06271a4aaf7c
ToppCell	Tracheal-10x5prime-Immune_Lymphocytic-B-B_plasma\|10x5prime / Cell types per location group and 10X technology with lineage, and cell group designations	IGKV1-39 IGKV1-17 IGKV1-16 IGKV1-12 IGKV1-6 IGKV1D-39 KLHL14 IGKV1D-12	1.93e-07	193	141	8	282b47dae6043eabb1e13d41d91c07b5ec21cd65
ToppCell	Tracheal-10x5prime-Immune_Lymphocytic-B-B_plasma-B_plasma_IgG\|10x5prime / Cell types per location group and 10X technology with lineage, and cell group designations	IGKV1-17 IGKV1-16 IGKV1-12 IGKV1-6 IGKV1-5 IGKV1D-39 KLHL14 IGKV1D-12	2.01e-07	194	141	8	a4a70369541876e1192df8828b63e3d1746ae3d9
ToppCell	5'-Adult-LargeIntestine\|Adult / Celltypes from developing, pediatric, Crohn's, & adult GI tract	IGKV1-27 IGKV1-17 IGKV1-16 IGKV1-6 MUC5B MUC12 IGKV1-5 MUC4	2.09e-07	195	141	8	600174e35574fe7c44dd923adcf43686e7b01e39
ToppCell	COVID_vent-Lymphocytic-Plasma_cell-IgM_Plasmablast\|COVID_vent / Disease condition, Lineage, Cell class and subclass	IGKV1-39 IGKV1-17 IGKV1-16 IGKV1-12 IGLV3-10 IGKV1-5 IGKV1D-39 KLHL14	2.17e-07	196	141	8	026a06d8d2089806823e6f6453d3ede84ae93bc6
ToppCell	Parenchymal-10x3prime_v2-Immune_Lymphocytic-B-B_plasma\|10x3prime_v2 / Cell types per location group and 10X technology with lineage, and cell group designations	IGKV1-39 IGKV1-17 IGKV1-12 IGLV3-10 IGKV1-5 IGKV1D-39 IGKV1D-33 IGKV1D-16	2.17e-07	196	141	8	b3d5540fe8ab9a9cbb9ab5350f5cb0e1aae93584
ToppCell	Parenchymal-10x5prime-Immune_Lymphocytic-B-B_cell-B_mature\|10x5prime / Cell types per location group and 10X technology with lineage, and cell group designations	IGKV1-39 IGKV1-33 IGKV1-27 IGKV1-17 IGKV1-12 SIDT1 IGKV1-5 IGKV1D-39	2.34e-07	198	141	8	d51ee880acc5804cd918105fac846a1528333d6c
ToppCell	5'-Parenchyma_lung-Epithelial-Epithelial_transtional-secretory-nasal_mucosa_goblet_cell-Goblet_(nasal)-Goblet_(nasal)_L.0.2.0.0\|5' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5	MUC5B KRT80 MET PTPRH NAV2 GPC2 MUC20	1.07e-06	167	141	7	d1a13d6ada572d8ddb2da95e6e122d2b705fad7f
ToppCell	367C-Lymphocytic-Plasma_cell-\|367C / Donor, Lineage, Cell class and subclass (all cells)	IGKV1-39 IGKV1-12 IGKV1-6 C11orf24 IGKV1-5 IGKV1D-39 IGKV1D-12	1.07e-06	167	141	7	f2185eb72f0137136f6d71af2a70168fded6c940
ToppCell	367C-Lymphocytic-Plasma_cell\|367C / Donor, Lineage, Cell class and subclass (all cells)	IGKV1-39 IGKV1-12 IGKV1-6 C11orf24 IGKV1-5 IGKV1D-39 IGKV1D-12	1.07e-06	167	141	7	5e768cf24699893e05d1bcb1c92dba2336943a64
ToppCell	metastatic_Brain-B_lymphocytes-Plasma_cells\|metastatic_Brain / Location, Cell class and cell subclass	IGKV1-27 IGKV1-17 IGKV1-16 IGKV1-12 IGKV1-6 IGKV1-5 IGKV1D-39	1.20e-06	170	141	7	53634da9e9c72f6400639954c286c6e38ea5a188
ToppCell	Control-Lymphoid-B_Plasma\|Control / Disease state, Lineage and Cell class	IGKV1-39 IGKV1-16 IGKV1-12 IGKV1-5 IGKV1D-39 IGKV1D-33 IGKV1D-16	1.30e-06	172	141	7	61e33836b8cb0f347f3e699eb587a37073b6fa4c
ToppCell	VE-plasma\|VE / Condition, Cell_class and T cell subcluster	IGKV1-39 IGKV1-16 IGKV1-12 IGKV1-6 KLHL14 IGKV1D-33 IGKV1D-12	1.57e-06	177	141	7	0c1cc0834de55717cb4f69d020339060ce2c9a03
ToppCell	VE-plasma-\|VE / Condition, Cell_class and T cell subcluster	IGKV1-39 IGKV1-16 IGKV1-12 IGKV1-6 KLHL14 IGKV1D-33 IGKV1D-12	1.57e-06	177	141	7	3a3c94cf30012e2aa266bc4d7fe772e45fa90f6d
ToppCell	5'-Parenchyma_lung-Immune_Lymphocytic-Lymphocytic_B-plasma_cell-Plasma_cells-Plasma_cells_L.1.7.0.1\|5' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5	IGKV1-39 IGKV1-27 IGKV1-17 IGKV1-16 IGKV1-12 IGKV1-6 IGKV1-5	1.82e-06	181	141	7	e47664a264a2c37390d1668ce04eef2e0172f4cb
ToppCell	BAL-Mild-Lymphocyte-B\|Mild / Location, Disease Group, Cell group, Cell class (2021.03.09)	IGKV1-39 IGKV1-16 IGKV1-12 IGKV1-6 PLEKHG1 IGKV1-5 IGKV1D-39	1.82e-06	181	141	7	700adfb41e4e377530f0dd31be89e12f109f3469
ToppCell	368C-Lymphocytic-Plasma_cell\|Lymphocytic / Donor, Lineage, Cell class and subclass (all cells)	IGKV1-39 IGKV1-17 IGKV1-12 IGKV1-6 IGLV3-10 IGKV1-5 IGKV1D-39	1.96e-06	183	141	7	7733cf919eda146efe41c93990658ce92db73aa8
ToppCell	cellseq-Immune-Lymphocytic_B-Lymphocytic_B-Plasma\|cellseq / Celltype signatures by Technology, Lineage, Lineage_subclass, Celltype_group, Cell_type2	IGKV1-39 IGKV1-12 IGKV1-5 IGKV1D-39 IGKV1D-33 IGKV1D-16 IGKV1D-12	1.96e-06	183	141	7	5ab4aa0304b832f98fff89b6c24ad5b7dd014c11
ToppCell	368C-Lymphocytic-Plasma_cell-\|Lymphocytic / Donor, Lineage, Cell class and subclass (all cells)	IGKV1-39 IGKV1-17 IGKV1-12 IGKV1-6 IGLV3-10 IGKV1-5 IGKV1D-39	1.96e-06	183	141	7	d91441cbf94f5c3b7c36f2ca3a46895870bd730f
ToppCell	10x5'-Liver-Lymphocytic_B_plasma-Plasma_cells\|Liver / Manually curated celltypes from each tissue	IGKV1-39 IGKV1-27 IGKV1-17 IGKV1-12 IGKV1D-39 KLHL14 IGKV1D-12	2.03e-06	184	141	7	6f70d8f8ab8362d51f8a58735d42223e06566397
ToppCell	3'-Broncho-tracheal-Immune_Lymphocytic-Lymphocytic_B-plasma_cell-Plasma_cells\|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5	IGKV1-27 IGKV1-17 IGKV1-16 IGKV1-12 IGKV1-6 IGKV1-5 IGKV1D-16	2.03e-06	184	141	7	15f2c10101ccc8ed059520fc082ee42593dff269
ToppCell	3'-Broncho-tracheal-Immune_Lymphocytic-Lymphocytic_B-plasma_cell\|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5	IGKV1-27 IGKV1-17 IGKV1-16 IGKV1-12 IGKV1-6 IGKV1-5 IGKV1D-16	2.03e-06	184	141	7	a90a58d9e319afa1cd572e4c2f516fadc42f56e5
ToppCell	3'-Parenchyma_lung-Immune_Lymphocytic-Lymphocytic_B-plasma_cell-Plasma_cells\|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5	IGKV1-39 IGKV1-17 IGKV1-12 IGKV1-6 IGLV3-10 IGKV1-5 IGKV1D-39	2.11e-06	185	141	7	6ec009e48e50471c28e914c402f500e56a88f8f2
ToppCell	COVID-19-Epithelial_cells-Airway_club\|COVID-19 / group, cell type (main and fine annotations)	MAGI3 MET NRXN3 ZNF608 NAV2 RP1 MUC4	2.11e-06	185	141	7	cfe6fd73d817e173fe803bc1683c291d9bcb8608
ToppCell	3'-Parenchyma_lung-Immune_Lymphocytic-Lymphocytic_B-plasma_cell\|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5	IGKV1-39 IGKV1-17 IGKV1-12 IGKV1-6 IGLV3-10 IGKV1-5 IGKV1D-39	2.11e-06	185	141	7	f49ad6401b2abd089e30eba245b11b5031ea2318
ToppCell	PBMC_fresh-frozen-Severe-critical_convalescent_d42-56-Lymphocytic-Lymphocytic_B-Plasma_cell\|Severe-critical_convalescent_d42-56 / Compartment, severity and other cell annotations on 10x 3' data (130k)	IGKV1-39 IGKV1-27 IGKV1-17 IGKV1-16 C11orf24 IGKV1-5 KLHL14	2.26e-06	187	141	7	d2296f2722a24b289fed7e6cfdc2105608437c3e
ToppCell	PBMC_fresh-frozen-Severe-critical_convalescent_d42-56-Lymphocytic-Lymphocytic_B-Plasma_cell-B_c05-MZB1-XBP1\|Severe-critical_convalescent_d42-56 / Compartment, severity and other cell annotations on 10x 3' data (130k)	IGKV1-39 IGKV1-27 IGKV1-17 IGKV1-16 C11orf24 IGKV1-5 KLHL14	2.26e-06	187	141	7	06a0f0a27569af89f86ed8cddb608454a3d40cc5
ToppCell	healthy_donor-Lymphocytic-Plasma_cell\|healthy_donor / Disease condition, Lineage, Cell class and subclass	IGKV1-17 IGKV1-6 IGKV1-5 IGKV1D-39 KLHL14 IGKV1D-16 IGKV1D-12	2.34e-06	188	141	7	bd53b0371154cff680226897b61c9809a239d1b6
ToppCell	Severe_COVID-19-Epithelial-undefined_Epi\|Severe_COVID-19 / Disease group,lineage and cell class （2021.01.30）	CACNB4 MUC16 MUC5B KRT80 MET PTPRH MUC4	2.43e-06	189	141	7	8cbd35320c7e7ff013ef0c0f13f8d875db1c53cd
ToppCell	droplet-Heart-4Chambers-21m-Mesenchymal-cardiomyocyte\|Heart / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation	AKAP6 DSC2 PPP1R3A PDE4DIP SCN5A SYPL2 MYO18B	2.60e-06	191	141	7	c172c9e17b893b290e4aa8af5e5e4cd3e4818372
ToppCell	droplet-Heart-4Chambers-21m-Mesenchymal-atrial_cardiomyocyte\|Heart / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation	AKAP6 DSC2 PPP1R3A PDE4DIP SCN5A SYPL2 MYO18B	2.60e-06	191	141	7	715f5b449b8e075959c05a5b38389df319663164
ToppCell	Parenchymal-NucSeq-Immune_Lymphocytic-B-B_plasma\|NucSeq / Cell types per location group and 10X technology with lineage, and cell group designations	IGKV1-27 IGKV1-16 RUNX2 IGKV1-5 NRXN1 IGKV1D-39 KLHL14	2.99e-06	195	141	7	0b0615553b9a1b60d666d074ce4260919e2d5642
ToppCell	droplet-Pancreas-PANCREAS-30m-Epithelial-pancreatic_B_cell\|Pancreas / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation	HUWE1 MADD KMT2C NRXN1 NAV2 FNIP1 SON	2.99e-06	195	141	7	3e519cffa6144a62b06124642a14c9ff39b76554
ToppCell	droplet-Pancreas-PANCREAS-30m-Epithelial-pancreatic_B_cell\|Pancreas / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation	HUWE1 MADD KMT2C NRXN1 NAV2 FNIP1 SON	2.99e-06	195	141	7	7796ea9247f4c63762f0de8490fed08b9717fa23
ToppCell	Parenchymal-10x5prime-Immune_Lymphocytic-B-B_cell\|10x5prime / Cell types per location group and 10X technology with lineage, and cell group designations	IGKV1-39 IGKV1-33 IGKV1-17 IGKV1-12 IGKV1-5 KLHL14 IGKV1D-33	3.19e-06	197	141	7	76465bb2408c7c75f694e8f7cf1a606b796afc3a
ToppCell	Tracheal-10x5prime-Immune_Lymphocytic-B-B_cell-B_mature\|10x5prime / Cell types per location group and 10X technology with lineage, and cell group designations	IGKV1-33 IGKV1-17 IGLV3-10 IGKV1-5 IGKV1D-39 IGKV1D-33 IGKV1D-12	3.19e-06	197	141	7	da175e66d0a743a1b91d46f224b5ff1d37aa5410
ToppCell	Parenchymal-NucSeq-Epithelial-Epi_airway_secretory\|NucSeq / Cell types per location group and 10X technology with lineage, and cell group designations	MAGI3 RUNX2 PLEKHG1 MET ZNF608 RP1 MUC4	3.30e-06	198	141	7	af399569c718f5fd971d73a7926768c9311002a3
ToppCell	Parenchymal-NucSeq-Epithelial-Epi_airway_secretory-Secretory_Club\|NucSeq / Cell types per location group and 10X technology with lineage, and cell group designations	MAGI3 RUNX2 PLEKHG1 MET ZNF608 RP1 MUC4	3.30e-06	198	141	7	1408e02e053ad3406229bfe8189da03be6366e81
ToppCell	Neuron-Postmitotic-Excitatory_Neuron_-Newborn-35\|World / Primary Cells by Cluster	MAPT BAZ2B CEP170 NRXN3 NRXN1 ZNF608 PDE4DIP	3.30e-06	198	141	7	de5214a85fe017eb23d4aa8af624464f062ec57e
ToppCell	LPS_IL1RA-Endothelial-Endothelial-Gen_Cap\|LPS_IL1RA / Treatment groups by lineage, cell group, cell type	BAZ2B PLEKHG5 KMT2C HMCN1 ZNF608 CDH5 SON	3.53e-06	200	141	7	dccec522ab0d7fff62ad6273b02aa9022dbbb8eb
ToppCell	metastatic_Lymph_Node-B_lymphocytes-Plasma_cells\|metastatic_Lymph_Node / Location, Cell class and cell subclass	IGKV1-27 IGKV1-16 IGKV1-12 IGLV3-10 IGKV1-5 IGKV1D-39	6.14e-06	142	141	6	5ba3a33c2ee20be8baaed97536ca6e9d1de6752f
ToppCell	3'-GW_trimst-1-SmallIntestine-Mesenchymal-myocytic-myofibroblast_(RSPO2+)\|GW_trimst-1 / Celltypes from developing, pediatric, Crohn's, & adult GI tract	BAZ2B FOS PCDHB6 MUC12 MAST2 NRXN3	6.39e-06	143	141	6	39060dc1d87505a16e2df95140087c731f099570
ToppCell	390C-Lymphocytic-Plasma_cell-\|390C / Donor, Lineage, Cell class and subclass (all cells)	IGKV1-39 IGKV1-12 IGKV1-6 IGKV1-5 IGKV1D-33 IGKV1D-16	1.05e-05	156	141	6	4f92ca30755430db44402afc603d1ecd8bfc3617
Drug	Thioproperazine dimesylate [2347-80-0]; Down 200; 6.2uM; MCF7; HT_HG-U133A	DSC2 SPN DLGAP4 ADGRL1 C11orf24 NECTIN3 ITPKB PLEKHG3 HMGXB3	2.07e-06	196	131	9	2236_DN
Disease	autism spectrum disorder (implicated_via_orthology)	ZNF280A DSCAM DLGAP4 TSC1 MET NRXN3 NRXN1 SCN1A	3.71e-07	152	129	8	DOID:0060041 (implicated_via_orthology)
Disease	COMM domain-containing protein 1 measurement	IGKV1-17 IGKV1-16	1.90e-05	2	129	2	EFO_0802424
Disease	level of nuclear factor NF-kappa-B p105 subunit in blood serum	IGKV1-17 IGKV1-16	1.90e-05	2	129	2	OBA_2040323
Disease	autosomal dominant intellectual developmental disorder (is_implicated_in)	DIP2B SETD2 MED13	5.31e-05	17	129	3	DOID:0060307 (is_implicated_in)
Disease	Neurodevelopmental Disorders	DSCAM KMT2C SETD2 SETD5 SCN1A	5.64e-05	93	129	5	C1535926
Disease	Epilepsy, Atonic	CACNB4 SCN1A	1.13e-04	4	129	2	C0086236
Disease	Epilepsy, Tonic	CACNB4 SCN1A	1.13e-04	4	129	2	C0086241
Disease	Generalized convulsive epilepsy	CACNB4 SCN1A	1.13e-04	4	129	2	C0311334
Disease	Symptomatic Generalized Epilepsy	CACNB4 SCN1A	1.13e-04	4	129	2	C0270854
Disease	Generalized Nonconvulsive Seizure Disorder	CACNB4 SCN1A	1.13e-04	4	129	2	C0017332
Disease	Epilepsy, Akinetic	CACNB4 SCN1A	1.13e-04	4	129	2	C0347869
Disease	cholangiocarcinoma (is_marker_for)	MUC16 MUC5B MET MUC4	1.81e-04	64	129	4	DOID:4947 (is_marker_for)
Disease	Epilepsy, Generalized	CACNB4 SCN1A	2.81e-04	6	129	2	C0014548
Disease	monocyte percentage of leukocytes	TRERF1 CRYBG2 HLX MADD RYBP LHX2 SETD2 PTPRH PI4KA PHLPP1 HMGXB3	3.78e-04	731	129	11	EFO_0007989
Disease	arrhythmogenic right ventricular cardiomyopathy (is_marker_for)	DSC2 SCN5A	3.93e-04	7	129	2	DOID:0050431 (is_marker_for)
Disease	arteriosclerosis (implicated_via_orthology)	LIPE MAP3K7	3.93e-04	7	129	2	DOID:2349 (implicated_via_orthology)
Disease	Liver carcinoma	MAPT FOS IRF2 TSC1 MED1 MET PNPT1 KMT2C SPRTN	4.03e-04	507	129	9	C2239176
Disease	anti-GAD65 autoimmune neurological syndromes	NEO1 NAV2 MUC22	4.82e-04	35	129	3	EFO_0803379
Disease	Conventional (Clear Cell) Renal Cell Carcinoma	TSC1 BRD3 MET SETD2 MUC4	4.96e-04	148	129	5	C0279702
Disease	Early Childhood Epilepsy, Myoclonic	SCN1A RAPGEF2	5.22e-04	8	129	2	C0393695
Disease	Idiopathic Myoclonic Epilepsy	SCN1A RAPGEF2	5.22e-04	8	129	2	C0338478
Disease	Symptomatic Myoclonic Epilepsy	SCN1A RAPGEF2	5.22e-04	8	129	2	C0338479
Disease	Benign Infantile Myoclonic Epilepsy	SCN1A RAPGEF2	5.22e-04	8	129	2	C0751120
Disease	phenol sulfate measurement	PLEKHG1 MYO18B	5.22e-04	8	129	2	EFO_0021011
Disease	Myoclonic Encephalopathy	SCN1A RAPGEF2	5.22e-04	8	129	2	C0438414
Disease	Myoclonic Absence Epilepsy	SCN1A RAPGEF2	5.22e-04	8	129	2	C0393703
Disease	blood titanium measurement	BAZ2B RP1 PDZD2	5.24e-04	36	129	3	EFO_0021532
Disease	Parkinson disease	MAPT MUC19 MUC12 ITPKB MMRN1 ZNF608 MED13	5.44e-04	321	129	7	MONDO_0005180
Disease	physical activity	CRYBG2 DLGAP4 PLEKHG1 AEBP2	6.12e-04	88	129	4	EFO_0003940
Disease	Cognition Disorders	MAPT TSC1 MET	6.16e-04	38	129	3	C0009241
Disease	Paroxysmal atrial fibrillation	AKAP6 MAPT SCN5A NAV2 MYO18B	6.29e-04	156	129	5	C0235480
Disease	familial atrial fibrillation	AKAP6 MAPT SCN5A NAV2 MYO18B	6.29e-04	156	129	5	C3468561
Disease	Persistent atrial fibrillation	AKAP6 MAPT SCN5A NAV2 MYO18B	6.29e-04	156	129	5	C2585653
Disease	idiopathic pulmonary fibrosis (is_implicated_in)	MUC5B SETD2	6.69e-04	9	129	2	DOID:0050156 (is_implicated_in)
Disease	Myoclonic Epilepsy	SCN1A RAPGEF2	6.69e-04	9	129	2	C0014550
Disease	Atrial Fibrillation	AKAP6 MAPT SCN5A NAV2 MYO18B	7.06e-04	160	129	5	C0004238
Disease	epilepsy (implicated_via_orthology)	SLC12A6 MAPT SCN1A SCN5A MIB1	7.67e-04	163	129	5	DOID:1826 (implicated_via_orthology)
Disease	eosinophil count	TRERF1 DIP2B MAPT NCKIPSD HECTD4 HLX BRD3 RUNX2 GGCX ITPKB PPP1R3A SETD2 FNIP1 UBAC2 MUC22 TP53BP1	7.94e-04	1488	129	16	EFO_0004842
Disease	generalized epilepsy with febrile seizures plus 2 (implicated_via_orthology)	SCN1A SCN5A	8.34e-04	10	129	2	DOID:0111294 (implicated_via_orthology)
Disease	Dravet syndrome (implicated_via_orthology)	SCN1A SCN5A	8.34e-04	10	129	2	DOID:0080422 (implicated_via_orthology)
Disease	Epilepsy, Myoclonic, Infantile	SCN1A RAPGEF2	8.34e-04	10	129	2	C0917800
Disease	otitis media (is_marker_for)	MUC5B MUC4	8.34e-04	10	129	2	DOID:10754 (is_marker_for)
Disease	Malignant neoplasm of breast	AKAP6 TRERF1 FOS NUP214 RB1CC1 AREG PPP1R3A ZCCHC14 SETD2 LIPE GPC2 CDH5 TP53BP1	8.74e-04	1074	129	13	C0006142
Disease	fibrinogen measurement, tissue plasminogen activator measurement	DIP2B HECTD4 FNIP1	1.01e-03	45	129	3	EFO_0004623, EFO_0004791
Disease	fibrinogen measurement, plasminogen activator inhibitor 1 measurement	DIP2B HECTD4 FNIP1	1.01e-03	45	129	3	EFO_0004623, EFO_0004792
Disease	nucleus accumbens volume change measurement	DSCAM MUC16	1.02e-03	11	129	2	EFO_0021493
Disease	Myoclonic Astatic Epilepsy	SCN1A RAPGEF2	1.02e-03	11	129	2	C0393702
Disease	cortical thickness	AKAP6 DIP2B MAPT SIDT1 RUNX2 MAST2 PLEKHG1 NEO1 SETD5 PI4KA NAV2 MAP3K7 PDZD2	1.21e-03	1113	129	13	EFO_0004840
Disease	generalized epilepsy with febrile seizures plus (implicated_via_orthology)	SCN1A SCN5A	1.22e-03	12	129	2	DOID:0060170 (implicated_via_orthology)
Disease	Epilepsy	CACNB4 FOS TSC1 SCN1A	1.36e-03	109	129	4	C0014544
Disease	cholangiocarcinoma (biomarker_via_orthology)	MET MUC4	1.43e-03	13	129	2	DOID:4947 (biomarker_via_orthology)
Disease	Infantile Severe Myoclonic Epilepsy	SCN1A RAPGEF2	1.43e-03	13	129	2	C0751122
Disease	receptive language perception, parental genotype effect measurement	MUC19 PLEKHG1	1.67e-03	14	129	2	EFO_0005686, EFO_0005939
Disease	white matter microstructure measurement	DIP2B MAPT RUNX2 MAST2 PLEKHG1 TTLL4 NAV2	1.68e-03	390	129	7	EFO_0005674
Disease	factor XI measurement, fibrinogen measurement, tissue plasminogen activator measurement, factor VII measurement	DIP2B HECTD4 FNIP1	1.91e-03	56	129	3	EFO_0004619, EFO_0004623, EFO_0004694, EFO_0004791
Disease	amyotrophic lateral sclerosis, age at onset	CCDC192 NRXN3	1.92e-03	15	129	2	EFO_0004847, MONDO_0004976
Disease	obsolete_red blood cell distribution width	CCDC192 DIP2B OGT BAZ2B HECTD4 BRD3 PLEKHG5 CEP170 PLEKHG1 NEO1 PTPRH MUC17 RP1 MUC4	2.33e-03	1347	129	14	EFO_0005192
Disease	pancreatic ductal carcinoma (is_marker_for)	MUC5B MET MUC4	2.44e-03	61	129	3	DOID:3587 (is_marker_for)
Disease	C-reactive protein measurement	AKAP6 TRERF1 SNX17 KCTD8 HLX RICTOR BRD3 MADD NEO1 ZNF608 SETD5 TAF4 TP53BP1	2.45e-03	1206	129	13	EFO_0004458
Disease	Sarcomatoid Renal Cell Carcinoma	TSC1 MET SETD2 MUC4	2.45e-03	128	129	4	C1266043
Disease	Chromophobe Renal Cell Carcinoma	TSC1 MET SETD2 MUC4	2.45e-03	128	129	4	C1266042
Disease	Collecting Duct Carcinoma of the Kidney	TSC1 MET SETD2 MUC4	2.45e-03	128	129	4	C1266044
Disease	Papillary Renal Cell Carcinoma	TSC1 MET SETD2 MUC4	2.45e-03	128	129	4	C1306837
Disease	Renal Cell Carcinoma	TSC1 MET SETD2 MUC4	2.45e-03	128	129	4	C0007134
Disease	Cardiomyopathies	DSC2 MAPT SGCB SCN5A	2.59e-03	130	129	4	C0878544
Disease	eye morphology measurement	AKAP6 CAPRIN2 RP1 MYO18B MAP3K7	2.76e-03	218	129	5	EFO_0007858
Disease	ovarian neoplasm	MUC16 AREG MET TP53BP1	2.89e-03	134	129	4	C0919267
Disease	neutrophil count	TRERF1 DSCAM MAPT HECTD4 HLX MAGI3 BRD3 MAST2 MET LHX2 SETD2 SYPL2 RP1 MUC22	2.94e-03	1382	129	14	EFO_0004833
Disease	Brugada syndrome	SCN5A MYO18B	3.09e-03	19	129	2	MONDO_0015263
Disease	Malignant neoplasm of ovary	MUC16 AREG MET TP53BP1	3.13e-03	137	129	4	C1140680
Disease	radiation-induced disorder	MUC12 NRXN1 MAP3K7	3.19e-03	67	129	3	EFO_0009565
Disease	Osteoarthritis of hip	MAPT RUNX2	3.42e-03	20	129	2	C0029410
Disease	Intellectual Disability	AKAP6 PNPT1 KMT2C SETD2 NRXN1 SCN1A MED13	3.59e-03	447	129	7	C3714756
Disease	quinolinic acid measurement	CDH19 RYBP	3.77e-03	21	129	2	EFO_0010528
Disease	systemising measurement	DSCAM CEP170	3.77e-03	21	129	2	EFO_0010221
Disease	cognitive function measurement	AKAP6 DSCAM NCKIPSD BRD3 CDH19 RYBP ZCCHC14 PLEKHG1 NRXN3 NRXN1 ZNF608 PHLPP1 MYO18B MAP3K7	4.08e-03	1434	129	14	EFO_0008354
Disease	esophagus squamous cell carcinoma (is_marker_for)	RICTOR RUNX2 SETD5	4.22e-03	74	129	3	DOID:3748 (is_marker_for)
Disease	gait measurement	AKAP6 PPP1R3A NRXN3 SETD5	4.32e-03	150	129	4	EFO_0007680

Protein segments in the cluster

Peptide	Gene	Start	Entry
ATEASDSRKMGTPSS	PI16	221	Q6UXB8
SEGRSTDSPVTMKSS	ZNF280A	106	P59817
TEISESGMTVRSTGS	CEP170	616	Q5SW79
MVSAGVPNSSEETAT	ERVK-25	86	P61579
PMVSKGAESSRSSEE	BRD3	431	Q15059
DVDSTISSGRSTPAM	AEBP2	231	Q6ZN18
VTSRSEMSSGSEISP	AREG	51	P15514
RTPASSSEMDDGPSR	DDX4	36	Q9NQI0
TESSFMAGDINSTPT	ADGRL1	1161	O94910
MESGERLPSSAASST	BAZ2B	1	Q9UIF8
STSRSKSEVSPGMAF	ARHGEF5	911	Q12774
SSRRPGTSVVSSASM	ANKIB1	806	Q9P2G1
EMVSGTFRATPTSTA	CACNB4	186	O00305
VISDNGMPSRTGTST	CDH5	556	P33151
SSVPSHSMSSRRDTD	DLGAP4	701	Q9Y2H0
EASPRSAMSTATVTV	DSC2	446	Q02487
STESSEHLRVASGPM	FAM90A10	136	A6NDY2
MAEAAAPGTTVTTSG	MKRN4P	1	Q13434
TMATSRARPTGTAST	MUC5B	1721	Q9HC84
MVSAGVPNSSEETAT	ERVK-19	86	P61572
MVSAGVPNSSEETAT	ERVK-6	86	Q69383
MVSAGVPNSSEETAT	ERVK-9	86	P61573
SMTPASSSSRPDRET	IRF2	316	P14316
STESSEHLRVASGPM	FAM90A7	136	A6NKC0
GPSSRSTDSSMEFSI	KIAA1107	211	Q9UPP5
ASSPRMESTAGITTT	RB1CC1	651	Q8TDY2
MESTAGITTTTSPRT	RB1CC1	656	Q8TDY2
VPETTLTMSETSNGD	MUC16	2681	Q8WXI7
ITFAMGDTSVSTSTP	MUC16	5751	Q8WXI7
ISGSAESTMLPEIST	MUC16	7291	Q8WXI7
RTEAISFSRTSMSGP	MUC16	7576	Q8WXI7
TEVISSRGTSMSGPD	MUC16	8451	Q8WXI7
SATERSASLSGMPTG	MUC16	8721	Q8WXI7
TRISTPLTTTGSAEM	MUC16	8771	Q8WXI7
ETISTGTVMPSLSEA	MUC16	10271	Q8WXI7
DMSDLVTSLVPSSGT	MUC16	11541	Q8WXI7
MPTSRDSTLGNTEET	MUC4	396	Q99102
LVGEVPSSMTTESTA	NRXN1	291	P58400
ISEMVSSSSSPGASA	KCTD8	16	Q6ZWB6
MTQSPSSLSASVGDR	IGKV1D-33	26	P01593
MTQSPSSLSASVGDR	IGKV1D-39	26	P04432
TSSAPTVEGENDTMS	KMT2C	1616	Q8NEZ4
GVSPAVMIRSSSQDS	MADD	1181	Q8WXG6
PSDASEQRVSMASSG	MAGI3	556	Q5TCQ9
MAPSDTERTEGSERS	HLX	386	Q14774
MTQSPSSVSASVGDR	IGKV1D-12	26	P01611
SRTPSTSDMAEEGRV	NCKAP5L	1291	Q9HCH0
IPERFSGSSSGTMAT	IGLV3-10	76	A0A075B6K4
SGSETARSVPDMDLS	FOS	281	P01100
DTVNTASRMESTGLP	GUCY2D	1001	Q02846
PVTMATDSLETSTGT	SPN	186	P16150
GPSTRRADTAMTTDD	MUC20	26	Q8N307
TGTRLTASSSVTMAP	MUC22	1561	E2RYF6
SMVTEEERPTTAAGT	GPC2	371	Q8N158
MSAEIATTPEARTSE	MMRN1	61	Q13201
EGRMDSPSATVVSAV	KRT80	391	Q6KB66
VTVMRDSSESSSSAP	HMGXB3	266	Q12766
SAGVMETTGPSAEVT	MUC19	5456	Q7Z5P9
GTSSSVQRAMPGTDE	PDZD2	461	O15018
SSSSAGEMIEAPSQV	MAP3K7	11	O43318
GASEVIRESSSTTGM	NRXN3	1556	Q9Y4C0
MDTADGVPVSSRVST	DIP2B	261	Q9P265
SSVSSISQVSPERGM	PI4KA	256	P42356
PMSAGRSTEEATSSA	NUP214	1486	P35658
SAIDRGDTETTMPSI	LHX2	31	P50458
GDTETTMPSISSDRA	LHX2	36	P50458
STESSDHLRVASGPM	FAM90A17	136	P0DV74
VRESSTVASDGSMEG	GPR101	306	Q96P66
LVGEVPSSMTTESTA	NRXN1	1296	Q9ULB1
DESSTGSLAMSTRPR	NOL8	226	Q76FK4
FPGTDSMEVSTSSSL	HECTD4	3041	Q9Y4D8
STESSDHLRVASGPM	FAM90A16	136	P0DV73
TAVSSQLEGSPMDTS	HUWE1	2846	Q7Z6Z7
SMSSSPSRETVGVDA	RICTOR	1231	Q6R327
PSRETVGVDATTMDT	RICTOR	1236	Q6R327
STESSDHLRVASGPM	FAM90A19	136	P0DV76
PSGSMKITETRTSDS	HMCN1	1131	Q96RW7
VGSRSPSMISNDSET	MIB1	801	Q86YT6
TSESTPESMSAREKA	PPP1R3A	736	Q16821
STESSDHLRVASGPM	FAM90A8	136	A6NJQ4
SDSEMSASVSGDRSP	NKX3-2	146	P78367
SSAISMGIVSVSSPD	HECTD1	1476	Q9ULT8
MSRSGDRTSTFDPSH	KLHL14	1	Q9P2G3
PTSESSMEDSPTTER	BTAF1	86	O14981
ASTDSRQTSGSPATM	AQP6	161	Q13520
FTPSMSSGLDTDTET	CCNL2	61	Q96S94
GDSMSPDSDTELRSQ	FNIP1	756	Q8TF40
DSSVPNTGTARMVET	C5	1236	P01031
RMSSSVTVRPVSSGE	CRYBG2	191	Q8N1P7
ASSGSETEFMTSETP	CAPRIN2	701	Q6IMN6
EEAVGRSSGSSPAME	MAST2	986	Q6P0Q8
MTQSPSTLSASVGDR	IGKV1-5	26	P01602
MTQSPSSLSASVGDR	IGKV1-6	26	A0A0C4DH72
MTQSPSSVSASVGDR	IGKV1-12	26	A0A0C4DH73
MTQSPSSLSASVGDR	IGKV1-16	26	P04430
MTQSPSSLSASVGDR	IGKV1-17	26	P01599
MTQSPSSLSASVGDR	IGKV1-27	26	A0A075B6S5
MTQSPSSLSASVGDR	IGKV1-33	26	P01594
MTQSPSSLSASVGDR	IGKV1-39	26	P01597
PSSISAMEATITERG	EMC1	841	Q8N766
PESDTSERSSMTSGS	CCDC192	31	P0DO97
RSEPMSEMSGATTSL	SLC12A6	56	Q9UHW9
SESAPTGTSIGTIMA	CDH19	266	Q9H159
MVRLSSSDSIGPDVT	MED1	766	Q15648
LRGNSETSSDTPEMS	LIPE	881	Q05469
MASSVGNVADSTEPT	OGT	1	O15294
GTEREMEETPTSRNS	PCDHB6	776	Q9Y5E3
EEPGSITNSMTSSER	RP1	1446	P56715
MTSIESSVTSDTPGV	MUC17	91	Q685J3
SSVTSDTPGVSSTRM	MUC17	96	Q685J3
TEARSSPTTSEGTSM	MUC17	2196	Q685J3
EISSSATSAEGTSMP	MUC17	2551	Q685J3
SSPTTAEGTSMRIST	MUC17	2731	Q685J3
AEGTSMRISTPSDGS	MUC17	2736	Q685J3
IPMEAASSASSTREG	DSCAM	1946	O60469
ARSVSPTTEMVSNES	MET	986	P08581
SSSPTVLNSSGRMDE	RUNX2	501	Q13950
MSSTESAGRTADKSP	SYPL2	1	Q5VXT5
VPGATTTSSAATETM	TAF4	576	O00268
TMSPSRSVANSGLSD	STRADA	311	Q7RTN6
DTTTPESTMTSGQAR	TMEM248	81	Q9NWD8
GRSPTSTEKRMSFES	PLEKHG3	486	A1L390
TMATEVAARVTSTGP	ITPKB	301	P27987
STESSDHLRVASGPM	FAM90A9	136	A6NNJ1
SRSSTPKGDMSAVND	RYBP	211	Q8N488
ESVRNTPSTDTMPAS	NEO1	1301	Q92859
EAASRMLTTVGPASS	NAV2	466	Q8IVL1
RGVDTVSRSSLEMSP	SCN5A	451	Q14524
SMSHLEAVSPSDSRG	SETD5	1136	Q9C0A6
MPDSVSTGSVFGRST	MED13	1926	Q9UHV7
VMVSTTRLPSSSSGD	SGCB	261	Q16585
RSSIVMGEPISQSSS	PNPT1	766	Q8TCS8
RRGPSASSVAVMTSS	NCKIPSD	106	Q9NZQ3
PATDDNGTTTETEMR	SCN1A	676	P35498
SSESSVGSDNIMSPV	AKAP6	581	Q13023
TSEDVTMAAASPVTL	C11orf24	51	Q96F05
MSEESDSLRTSPSVA	TTPAL	1	Q9BTX7
RMVARSSDTAGPSSV	RAPGEF2	1436	Q9Y4G8
MHFSIPETESRSGDS	SNX17	1	Q15036
SIEMRSSSEPSRVGV	PLPPR4	476	Q7Z2D5
DSGTSAASSPTIMRK	PLEKHG5	726	O94827
TMGEASASIPTTVGS	TSC1	1066	Q92574
MAVSAGSARTSPSSD	GGCX	1	P38435
MERSGPSEVTGSDAS	WDR70	1	Q9NW82
TIDESSSSPGRQMSS	SIDT1	371	Q9NXL6
MSDTSSVSLEVSPGS	TEX264	221	Q9Y6I9
TAVMQSGRPRSSSTT	TMCC1	146	O94876
SNVSSTGSIDMVDSP	MAPT	726	P10636
RTSSVLGMSVESAPA	TP53BP1	116	Q12888
MTSDDSVTGSELSPL	SETD2	696	Q9BYW2
TESASVMPSQDVSGS	SPRTN	386	Q9H040
ATDTMRTPSRQSATS	MYO18B	2136	Q8IUG5
SSSSSPMGVQAREES	ZCCHC14	421	Q8WYQ9
SDSRSEGMRSKASSP	ZNF608	951	Q9ULD9
VPSSSSGMASEISSE	PHLPP1	1466	O60346
MELSDSDRPVSFGST	PLEKHG1	1	Q9ULL1
IFSSSEPTSEARIGM	UBAC2	221	Q8NBM4
SAVSPSESVAMISRS	TTLL4	541	Q14679
GMTDPRTQSTSGTDI	PTPRH	516	Q9HD43
MVISTSPSGGSEADI	SON	1641	P18583
VVSSMPERASESSSE	SON	1771	P18583
GSMEVLSETSSSRPG	PPIP5K1	986	Q6PFW1
GSSMDCSTAREEPSS	TMEM266	406	Q2M3C6
VISRGSPMSFEDSSR	UBE3C	481	Q15386
LSPVSTVSTGEDSMV	ZNF473	156	Q8WTR7
TGMGDPASSDLTRVS	TRERF1	431	Q96PN7
STESSDHLRVASGPM	FAM90A18	136	P0DV75
MTQSPSSLSASVGDR	IGKV1D-16	26	P01601
LPASMTSSGVSEEST	MUC12	651	Q9UKN1
GSMQIPSRDDSTSLT	PDE4DIP	716	Q5VU43
GEMESTTTSFPNETA	NECTIN3	211	Q9NQS3